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Mammalian gp78 is an E3 ubiquitin ligase that is anchored at the membrane of 
the endoplasmic reticulum (ER). It regulates protein homeostasis by 
polyubiquitinating and targeting proteins for proteasomal degradation under both 
physiologic and stress conditions. To further test its role in vivo, we analyzed the 
gross embryonic morphology of zebrafish embryos in which gp78 was knocked down 
using morpholinos and in transgenic fish overexpressing wild-type gp78 or dominant-
negative gp78. We show that gp78 is highly conserved among vertebrates. Zebrafish 
gp78, similar to human gp78, can colocalize with mouse MmUBC7 in HeLa cells. In 
vitro ubiquitination assays confirmed that zebrafish gp78 is indeed an E3 ubiquitin 
  
ligase. Although gp78 was maternally and constitutively expressed during embryonic 
development, with relatively high expression levels in several tissues, such as liver 
and brain, the knockdown of endogenous gp78 or overexpression of wild-type or 
dominant-negative gp78 did not result in developmental defects, suggesting 
compensation by other E3 ubiquitin ligases during embryonic development. 
ER-associated protein degradation (ERAD) activity by the unfolded protein 
response (UPR) represents one of the mechanisms for restoring ER homeostasis. 
However, the significance of gp78 in the regulation of hepatic ER stress in vivo 
remains elusive. Here we report that zebrafish gp78 plays a key role in the regulation 
of hepatic ER stress under tunicamycin-induced stress, but not under physiologic 
conditions. Tunicamycin treatment induced ER stress and upregulated the expression 
of several key components of the gp78-mediated ERAD complex in the liver. 
Moreover, hepatic-specific overexpression of the dominant-negative form of gp78 
(gp78-R2M) rendered livers more sensitive to tunicamycin-induced ER stress, 
suggesting a role for gp78-mediated ERAD in the regulation of hepatic protein 
homeostasis. Moreover, the overexpression of gp78-R2M enhanced the expression of 
sterol response element binding protein (Srebp) target genes in response to ER stress, 
while this was not observed in fish overexpressing wild-type gp78. Together, these 
data indicate that gp78 plays a critical role in the regulation of hepatic ER stress and 
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Chapter 1: General Introduction 
1.  Maintenance of protein homeostasis in the endoplasmic 
reticulum 
Proteins destined for the secretory pathway are folded and matured in the lumen 
of the endoplasmic reticulum (ER) before they are transported to their final functional 
destinations. Proper folding is achieved by enzymes that modify proteins and by 
molecular chaperones that maintain polypeptide solubility and promote folding 
(Schubert et al 2000., Hampton et al 2002). To maintain the high fidelity of the 
secretory pathway, the conformations of proteins are constantly monitored by the ER 
quality control (ERQC) system. Proteins that eventually fail to achieve their native 
conformation after refolding are retained in the ER and eliminated by ER-associated 
degradation (ERAD) (Vembar et al 2008). Thus, ERAD is a protective mechanism to 
prevent the accumulation of misfolded proteins in the ER, and thereby safeguards the 
secretory pathway. When the load of misfolded proteins overwhelms the folding and 
degradation capacity of the ER, the unfolded protein response (UPR) is activated to 
restore ER homeostasis by limiting further loading of proteins into the ER, thus 
enhancing protein folding and elevating ERAD activity (Rutkowski et al 2004). 
Prolonged UPR, however, triggers apoptosis, which has been implicated in the 
pathophysiology of many diseases, such as neurodegenerative diseases, cancer, 
cardiovascular diseases, muscle wasting and diabetes (Malhotra et al 2007., Szegezdi 
et al 2006). 




ERAD is a complex process that removes misfolded proteins through 
degradation and thus helps maintain ER protein homeostasis. Misfolded ER proteins 
localize either fully (luminal proteins) or partially (membrane proteins) in the lumen 
of the ER, but their degradation occurs in the cytosol by the proteasomes. Thus, 
retrotranslocation or dislocation of these misfolded ER proteins to the cytosol is an 
absolute requirement for their elimination (Sommer et al 1993., Tsai et al 2002). 
Moreover, retrotranslocation is intimately associated with recognition of misfolded 
proteins on the luminal side of the ER and ubiquitination and proteasomal targeting 
on the cytosolic side (Vembar et al 2008., Hebert et al 1995). It is well established 
that ER membrane-associated ubiquitin ligase complexes coordinate substrate 
recognition, retrotranslocation, ubiquitination and degradation during ERAD (Kikkert 
et al 2005., Kostova et al 2007). gp78 is one of the ubiquitin ligases playing such a 
role (Fang et al 2001). Moreover, gp78 is unique among all known ERAD ubiquitin 
ligases in that it has multiple conserved domains that interact directly with 
components of both ubiquitination and retrotranslocation complexes. 
3.  gp78-mediated ERAD 
3.1  gp78-mediated ubiquitination 
Ubiquitination is a process during which proteins are modified with a single 
ubiquitin or a chain of ubiquitin monomers. It occurs through a cascading action of 
E1 ubiquitin-activating enzyme, E2 ubiquitin-conjugating enzyme and then E3 
ubiquitin ligase (Fang et al 2004) (Fig. 1 A). The complexity of ubiquitination is 
reflected by having two E1s, dozens of E2s and over a thousand of E3s in mammalian 




ubiquitin chains linked through one of the seven Lys residues (K6, K11, K27, K29, 
K33, K48, and K63) or the amino terminus or a mixture of Lys residues of ubiquitin 
(Ben-Saadon et al 2006, Behrends et al 2011). Each E3 can interact with and 
ubiquitinate one or several substrate proteins, and by working with different E2s, each 
E3 can assemble different polyubiquitin chains on its substrates. In other words, E2 
determines the linkage of polyubiquitination while E3 dictates substrate specificity 
( Behrends et al 2011, Ye et al 2009). A number of proteins containing ubiquitin-
binding domains (UBDs), such as the ubiquitin-interacting motif (UIM) and 
ubiquitin-associated (UBA) domains, recognize conjugated ubiquitin or polyubiquitin 
chains and the downstream effector proteins of signaling pathways or degradation 
machinery. Through these interactions UBD-containing proteins transmit ubiquitin-
dependent signals to the desired biological function or proteasomal degradation 
(Dikic et al 2009, Winget et al 2010). The nine topologically distinct polymeric 
ubiquitin chains achieve a remarkably diverse range functions in ubiquitin signaling, 
such as targeting proteins for degradation, apoptosis, signal transduction, gene 
transcription, DNA repair, cell cycle progression, immune responses, virus budding, 
protein trafficking, and receptor and channel endocytosis (Behrends et al 2011, Ye et 
al 2009, Dikic et al 2009). Many of these functions control the life and death of cells. 
Accordingly, aberrant ubiquitination has been widely associated with development of 
malignancies, diabetes, cardiovascular diseases, inflammatory disorders and many 
neurodegenerative diseases (Schwartz et al 2009, Weissman et al 2011). gp78 











Fig. 1. Two schematic models of ubiquitination.  
 
(A) Schematic representation of RING finger E3 ubiquitin ligase-catalyzed 
ubiquitination. S: substrate protein. (B) gp78/Ube2g2-mediated substrate (S) 
ubiquitination. From the left: two E2s (Ube2g2s) preassemble K48 ubiquitin chain 
on their active cysteines by aminolysis; the preassembled ubiquitin chain on the 































gp78 is a polytypic RING (really interesting new gene) finger protein and is 
localized in the ER (Fang et al 2001). It contains five predicted transmembrane 
domains followed by a RING finger, an oligomerization site (OS), a coupling of 
ubiquitin to ER degradation (Cue) domain, a Ube2g2-binding region (G2BR) and a 
p97/VCP-interacting motif (VIM) ( Fang et al 2001, Chen et al 2006, Li et al 2009, 
Ballar et al 2006) (Fig. 2). RING finger defines a family of E3 ubiquitin ligases 
(Lorick et al 1999), which led to the identification of gp78 as an E3 ubiquitin ligase 
acting in the ERAD pathway (Weissman et al 2001). Although the function of RING 
finger is to bind to ubiquitin-charged E2 to facilitate transfer of ubiquitin to a 
substrate, gp78 also binds ubiquitin-conjugating enzyme E2 G2 (Ube2g2) through 
G2BR in addition to its RING finger (Fang et al 2001, Chen et al 2006). It has been 
shown that its E3 activity requires the coordinated action of the RING finger, Cue 


















































Fig. 2. Multi-species sequences alignment of gp78  
Multiple sequence alignment was performed using DNAMAN. Conserved 
cytosolic domains are underlined. The transmembrane domains (TMs) are 





Mechanistically, binding to G2BR leads to conformational changes in Ube2g2 
that affect ubiquitin loading and significantly enhance the affinity of Ube2g2 to the 
RING finger (Das et al 2009). This unique dual binding mode of Ube2g2 to gp78 
optimizes the efficiency of gp78-mediated ubiquitination of misfolded ER proteins. 
The mechanism by which gp78 cooperates with Ube2g2 to assemble polyubiquitin 
chains has been elegantly demonstrated (Li et al 2007) (Fig. 1 B). gp78/Ube2g2-
mediated polyubiquitination involves preassembly of K48 polyubiquitin chains at the 
catalytic cysteine of Ube2g2. The extension of Ube2g2-anchored polyubiquitin chains 
is achieved by an aminolysis-based transfer reaction between two Ube2ge molecules 
that each carries a ubiquitin moiety on its active cysteine. gp78 oligomerization 
mediated by its OS leads to simultaneous binding of multiple Ube2g2 molecules in 
close proximity, which allows ubiquitin moieties to be transferred between 
neighboring Ube2g2s to form active site-linked polyubiquitin chains. These 
polyubiquitin chains are then transferred en bloc to substrate proteins (Li et al 2009). 
gp78 appears to represent an example of convergent evolution with functions of 
both yeast ERAD E3 HMG-CoA reductase degradation protein-1 (Hrd1p) and its 
cofactor Cue1p found within a single molecule. Hrd1p is a polytypic RING finger E3 
and Cue1p is a type III transmembrane protein (Bordallo et al 1999, Bays et al 2001, 
Biederer et al 1997). Cue1p contains a Cue domain and a Ubc7p-binding region 
(U7BR) that is functionally analogous to G2BR (Kostova et al 2009). Ubc7p is the 
yeast homolog of Ube2g2 and also interacts with the RING finger of Hrd1p (Deak et 
al 2001). Association of U7BR with Ubc7p activates the RING finger-dependent E3 




Like Ube2g2, Ubc7p also assembles polyubiquitin chains at its active site and 
ubiquitinates substrates by en bloc transferring (Ravid et al 2007).  
In addition to functioning as an E3, gp78 was reported to function as a 
polyubiquitin chain assembly factor (E4) to catalyze polyubiquitination of 
CFTRF508 (deletion of phenylalanine 508 of the cystic fibrosis transmembrane 
conductance regulator) (Morito et al 2008). In this case, another RING finger protein 
RMA1 acts as an E3 to ubiquitinate CFTRF508. gp78 then recognizes the ubiquitin 
that is already conjugated to CFTRF508 via its Cue domain and catalyzes 
polyubiquitination of CFTRF508. Whether this E4 function of gp78 is specific for 
CFTRF508 or general to all its substrates remains to be explored. 
3.2  gp78 directly links ubiquitination to retrotranslocation 
The general scheme of ERAD has been well established. ERAD substrates are 
first recognized and delivered to the membrane-anchored E3 ubiquitin ligase 
complexes by ER luminal chaperones and lectins followed by retrotranslocation, 
ubiquitination and proteasomal degradation (Vembar et al 2008). In budding yeast, 
two complexes, one composed of the Hrd1p ubiquitin ligase degrades substrates with 
lesions exposed to the ER lumen or transmembrane, namely ERAD-L and ERAD-M, 
whereas the other composed of Doa10p ubiquitin ligase disposes of substrates with 
lesions on the cytosolic side of the ER, namely ERAD-C (Carvalho et al 2006, Denic 
et al 2006). These ERAD complexes are essentially conserved in mammalian cells, 
but the three ERAD pathways described in yeast are not well defined in mammalian 




gp78 has been reported to degrade all types of substrates, for example, the 
luminal substrate, the Z variant of -1-antitrypsin (ATZ), the membrane substrate 
HMG-CoA reductase, and the cytosolic substrate mutant SOD1 (see Table 1 for a list 
of substrates for gp78). How luminal substrates, such as ATZ, are targeted to gp78 is 
not known. As ATZ is a glycosylated substrate, mannose-trimming factors, such as 
ER mannosidase I (ER ManI) or one or more ER degradation-enhancing-
mannosidase-like proteins (EDEMs) (Ruddock et al 2006, Hebert et al 2010), must be 
involved in ATZ degradation mediated by gp78. Binding immunoglobulin protein 
(BiP/grp78) and the ER lectin OS-9, whose function is to target substrates to the Hrd1 
complexes, are associated with gp78 (Zhong, Y and Fang, S, unpublished data), 
suggesting that they may target substrates to the gp78 complex as well. In contrast, 
XTP3-B, another ER lectin for substrate targeting, does not associate with gp78, and 
thus is unlikely to function with gp78 (Hosokawa et al 2008). gp78 appears to 
recognize membrane substrates via different adaptor proteins, such as Derlin1, insig-1 
and SPFH1/SPFH2 that recruit CFTRF508, HMG-CoA reductase and possibly 
inositol 1,4,5-trisphosphate (IP(3)) receptors, respectively (Younger et al 2006, Sun et 
al 2006, Wang et al 2008, Song et al 2005, Jo et al 2011, Pearce et al 2007). We do 
not know whether the transmembrane domains of gp78 directly recognize substrates. 
As expected, gp78 recognizes its cytosolic substrates, such as mutant huntingtin (htt) 
and SOD1 using its cytosolic tail (Yang et al 2010, Ying et al 2009). Therefore, the 
function of gp78 is not confined to any particular ERAD pathway defined in yeast. 
After delivery to the gp78 complex (Table 2), luminal and probably some 




determined by the topology of gp78. As in all known ERAD E3s, the E3-active 
domain-the RING finger of gp78 is localized on the cytosolic surface of the ER 
(Zhong et al 2011). Retrotranslocation enables access of luminal substrates to the E3 
activity for ubiquitination. Recent studies suggest that cytosolic exposure of luminal 
substrates is promoted by a cooperative action of importin  and RanGDP (Zhong et 
al 2011), although the underlying mechanism is not known. Following ubiquitination, 
the cytosolic AAA ATPase (ATPase associated with various cellular activities) 
p97/VCP/Cdc48 and its cofactors Ufd1 and Npl4 are recruited to the cytosolic surface 
of the ER to extract polyubiquitinated substrates into the cytosol through hydrolysis 
of ATP (Tsai et al 2002, Bays et al 2002) (Fig. 3 A). The role of the cofactors is to 
enhance the binding of p97/VCP with the polyubiquitinated substrates (Ye et al 2003). 
The polyubiquitin chain conjugated to the substrates provides a handle for the 
p97/VCP complex to pull the substrate from the ER. How p97/VCP along with Ufd1 
and Npl4 are recruited to the ER remains unclear. Evidence suggests that the 
recruitment may be a concerted effort of several proteins in the ERAD complex. For 
example, p97/VCP/Cdc48 interacts with Hrd1, another well-established polytypic 
ERAD E3, and also several other proteins that interact with Hrd1, including Derlin1-3, 
VIMP, Erasin, UbxD8 and Herp (Ye et al 2004, Ye et al 2005, Lilley et al 2005, 
Lilley et al 2004, Schulze et al 2005, Liang et al 2006, Mueller et al 2008). Although 
we do not know whether these multiple interactions lead to recruitment of the 
p97/VCP-Ufd1-Npl4 complex, functional studies in both yeast and mammalian cells 
have shown that the p97/VCP/Cdc48-Ufd1-Npl4 complex is required for degradation 




The gp78 complex contains similar membrane components to those of the Hrd1 
complex. Therefore, proteins in the gp78 complex also make multiple contacts with 
p97/VCP. Evidence suggests that the gp78-p97/VCP interaction is most critical for 
coupling ubiquitination with retrotranslocation (Zhong et al 2004). gp78 contains a 
p97/VCP-interacting motif (VIM) near its C-terminus (Ballar et al 2006). The VIM 
has a high affinity towards p97/VCP and is sufficient to recruit p97/VCP to the ER 
surface (Ballar et al 2006, Hanzelmann et al 2011). Deletion of the VIM from gp78 
stabilizes CD3δ, a well-established gp78 substrate. Moreover, the stabilized CD3δ is 
highly ubiquitinated, suggesting that loss of VIM in gp78 results in failure to recruit 
p97/VCP, which in turn results in failure to extract ubiquitinated CD3δ ( Zhong et al 
2004). The VIM of gp78 interacts with the ND1 domain of p97/VCP that is also the 
binding site for Ufd1 (Ballar et al 2006). In addition, Ufd1 bridges the interaction of 
the Ufd1-Npl4 dimer with p97/VCP (Meyer et al 2000). Therefore, gp78 and the 
Ufd1-Npl4 dimer form mutually exclusive complexes with p97/VCP (Ballar et al 
2006, Stapf et al 2011). Therefore, it is unlikely that gp78 can recruit p97/VCP along 
with the Ufd1-Npl4 dimer. Functional studies indeed show that gp78-mediated 
ERAD is independent of Ufd1, but surprisingly, requires Npl4 (Ballar et al 2006, 
Ballar et al 2011). Nevertheless, the interaction between gp78 and p97/VCP enhances 
p97/VCP-polyubiquitin binding (Zhong et al 2004), suggesting that Npl4 and the Cue 
domain of gp78 may play an analog role to that of the Ufd1-Npl4 dimer. However, 
the Ufd1-Npl4 independent retrotranslocation has recently been shown for the human 
cytomegalovirus protein US2-mediated degradation of MHC class I heavy chain from 




might exist. Reminiscent of ERAD, the yeast Cdc48 is recruited to stressed 
mitochondria, retrotranslocates ubiquitinated proteins from the outer mitochondria 
membrane and delivers ubiquitinated proteins to the proteasome for degradation (Heo 
et al 2010). Interestingly, Cdc48 is recruited to mitochondria by the VIM of Vms1. 
Moreover, Vms1 recruits Cdc48-Npl4 complex to retrotranslocate proteins 
independent of Ufd1. Moreover, Vms1 does not directly interact with Npl4. The 
Vms1-Npl4 interaction is bridged by Cdc48 (Heo et al 2010). The mammalian 
homolog of Vms1, ANKZF1, although not evaluated, is likely to play the same role 
(Stapf et al 2011, Heo et al 2010). Since gp78-mediated ERAD requires p97/VCP and 
Npl4 independent of Ufd1 and gp78 contains a VIM, we predict that gp78 recruits 
p97/VCP-Npl4 to the ER during ERAD (Fig. 3 A).  
Retrotranslocation is thought to occur through a proteinaceous channel.  
Although the identity of this channel remains elusive, it must be associated with the 
E3 ubiquitin ligase complexes and formed by transmembrane protein(s).  Previous 
studies suggest that the sec61 translocon may also serve as a channel for 
retrotranslocation during ERAD (Wiertz et al 1996). Other transmembrane proteins, 
such as Derlins, gp78 and Hrd1 have been suggested to be part of the 
retrotranslocation channel (Schekman et al 2004, Meusser et al 2005). The yeast 
homolog of Hrd1, Hrd1p, has indeed been shown to be the retrotranslocation channel 
in yeast (Carvalho et al 2010). It is not known, however, whether Hrd1 plays the same 
role. Although Derlin1 was considered as the best candidate channel protein, recent 
studies indicate that Derlin1 is a rhomboid pseudoprotease that is unlikely to function 




transmembrane domains and can form large oligomers. It is tempting to speculate that 
its oligomerization may form the retrotranslocation channel. 
It is known that at least some of the glycosylated substrates are degraded through 
the gp78-mediated pathway. Removal of glycans from substrates is an essential step 
required for degradation by the proteasomes. Indeed, gp78 is associated, via p97/VCP, 
with the peptide N-glycanase (PNGase), a cytosolic enzyme that deglycosylates 
misfolded glycoproteins, and mHR23B, a ubiquitin chaperone that delivers 
polyubiquitinated substrates to the proteasomes (Li et al 2005, Li et al 2008). Another 
important issue is how cells maintain the solubility of retrotranslocated substrates 
before they reach the proteasomes. Previous studies suggest that gp78 appears to play 
such a role (Shen et al 2006).  It is now known that gp78 associates with a 
multiprotein complex comprising Bag6, Ubl4A and Trc35, which chaperones 
retrotranslocated polypeptides en route to the proteasome. Bag6 contains a 
chaperone-like activity capable of maintaining an aggregation-prone substrate in an 
































































































Fig. 3. A simplified view of gp78 and Hrd1-mediated ERAD pathways and 
their regulations by SVIP.  
 
(A) gp78 recruits p97/VCP-Npl4(N) to the cytosolic surface of the ER for 
coupling ubiquitination with retrotranslocation to enhance ERAD; (B) SVIP(S) is 
anchored to membrane via myristoylation and sequesters Derlin1, p97/VCP and 
probably Npl4(N) away from gp78 leading to inhibition of ERAD; (C) p97/VCP-
Ufd1(U)-Npl4(N) complex is recruited to the Hrd1 complex to couple 
ubiquitination with retrotranslocation. SVIP may inhibit Hrd1-mediated ERAD by 





4.  Maintenance of protein homeostasis by gp78-mediated 
ERAD 
4.1  Regulation of physiological processes by gp78-mediated ERAD 
Increasing evidence indicates that gp78-mediated ERAD plays an important role 
in the regulation of physiological processes. Apolipoprotein B-100 (ApoB-100), an 
essential protein for the assembly and secretion of very low-density lipoproteins 
(VLDL) from the liver, is the first physiological substrate identified for gp78 (Liang 
et al 2003, Fisher et al 2011) (Table 1). ApoB-100 is degraded by ERAD when lipid 
availability limits the assembly of VLDL (Fisher et al 2011). This is part of the 
quality control mechanism that eliminates orphan subunits of protein complexes. 
gp78 and p97/VCP have been implicated in the proteasomal degradation of ApoB-
100 ( Liang et al 2003, Fisher et al 2011, Fisher et al 2008). Overexpression of gp78 
was shown to increase ubiquitination and proteasomal degradation of ApoB-100, with 
reduced secretion of ApoB-100 in HepG2 cells (Liang et al 2003). By contrast, 
knockdown of gp78 expression decreased ApoB-100 ubiquitination and 
retrotranslocation. Concomitantly, VLDL assembly is enhanced and triacylglycerol 
secretion is increased. gp78-mediated ubiquitination commits ApoB-100 to p97/VCP-
mediated retrotranslocation ( Fisher et al 2011). Therefore, gp78 plays an important 
regulatory role in VLDL assembly through ubiquitination of ApoB-100. 
gp78 also has an established role in the regulated degradation of 3-hydroxy-3-
methylglutaryl-coenzyme A reductase (HMGCR), a key enzyme that catalyzes the 
conversion of HMG-CoA to mevalonate in the rate-limiting step of cholesterol 




mediated by sterol and nonsterol metabolites of mevalonate ( Goldstein et al 2006). 
One mechanism for the feedback regulation involves rapid degradation of HMGCR 
through ERAD according to studies in cultured cells (Sever et al 2003). 
Accumulation of sterols in the ER membrane triggers binding of the ER membrane 
proteins Insig-1 and Insig-2 to the sterol-sensing domain of HMGCR. Insig-1 in turn 
interacts the N-terminal transmembrane domains of gp78, thereby targeting HMGCR 
to the gp78 complex. gp78 then catalyzes polyubiquitination of HMGCR through its 
interaction with the E2 Ube2g2 (Song et al 2005, Goldstein et al 2006). Ufd1 acts as a 
cofactor for gp78 to promote HMGCR ubiquitination (Cao et al 2007). The 
ubiquitinated HMGCR is extracted from the ER by p97/VCP and then delivered to 
the proteasomes for degradation (Song et al 2005). Taken together, gp78 binds to 
HMGCR in an Insig1-dependent and sterol regulated manner. When cells are 
depleted of sterols, gp78 targets Insig-1 for degradation leading to increases in sterol 
synthesis by HMGCR (Lee et al 2006). It is worth noting that Hrd1p is the E3 
ubiquitin ligase involved in ERAD of HMGCR in yeast (Hampton et al 1996), while 
Hrd1, the mammalian homolog of Hrd1p, is not involved in the regulation of 
HMGCR degradation in mammalian cells (Song et al 2005, Nadav et al 2003). 
The liver cytochrome P450 (CYP) enzymes have recently joined the list of gp78 
substrates. Specifically, CYP3A4 and CYPE21 have been shown to be substrates for 
gp78 (Kim et al 2010, Wang et al 2011). CYP3A4 is responsible for the metabolism 
of the majority of xenobiotics including anticancer agents. The levels of CYP3A4 
expression have been proposed to be a factor responsible for the variability in clinical 




CYP3A4 leading to its degradation by the proteasomes. This finding has important 
clinical implications, because most anticancer agents have very narrow therapeutic 
windows, thus even slight changes in CYP3A4 levels could alter the exposure of the 
drug and result in either insufficient efficacy or toxicity (Peer et al 2011). Liver 
CYP2E1 is responsible for the biotransformation of clinically relevant drugs, low 
molecular weight xenobiotics, carcinogens and endogenous ketones. gp78 is able to 
ubiquitinate and target CYP2E1 for proteasomal degradation (Wang et al 2011). 
Phosphorylation of CYP2E1 and CYP3A4 may serve to engage the gp78/Ube2g2 
complex to enhance their ubiquitination. The hepatic function of gp78 in vivo is 
further highlighted by its high level of expression in mouse liver compared with other 
organs (Ballar, P and Fang, S, unpublished data). Thus, gp78 may play important 
roles in the regulation of drug metabolism in liver. 
4.2  Regulation of pathological processes by gp78-mediated ERAD 
The significance of gp78-mediated ERAD is underscored by its association with 
not only physiological proteins but also proteins that are linked to human diseases, 
such as KAI1, ATZ, and CFTRF508, and mutant huntingtin (htt), neuroserpin, 
ataxin-3 and SOD1. 
gp78 was originally identified as a 78-kDa glycoprotein that promotes tumor 
metastasis (Nabi et al 1987). Subsequently, it was shown to be the tumor autocrine 
motility factor (AMF) receptor (AMFR) (Silletti et al 1991, Nabi et al 1990). 
Consistently, gp78 has been shown to be highly expressed in various cancers, such as 
bladder cancer, colorectal cancer, esophageal cancer, gastric cancer and 




(Fairbank et al 2009). This is in accord with the observation that patients with 
increased expression of gp78 have significantly worse disease-free survival rates 
(Endo et al 2006). The correlation of the elevated expression in tumors and increased 
metastasis has been solely attributed to the function of gp78 as AMFR. However, 
gp78 also promotes metastasis through the ERAD pathway (Tsai et al 2007). gp78 
associates with and targets the transmembrane metastasis suppressor, KAI1 (also 
known as CD82), for degradation. Reduction of gp78 expression increases the 
abundance of KAI1 and reduces the metastatic potential of tumor cells, an effect that 
is largely abrogated by concomitant suppression of KAI1. This inverse relationship 
between these proteins was revealed in a human sarcoma tissue microarray (Tsai et al 
2007). When overexpressed in mammary glands, gp78 promotes cell proliferation and 
nontumorigenic ductal outgrowth mediated by the metastasis suppressor KAI1 (Joshi 
et al 2010). Therefore, gp78 may promote tumor cell proliferation, invasion and 
metastasis by more than one mechanism. 
Another pathogenic role of gp78 is in cystic fibrosis (CF). CF is a common 
autosomal recessive disease caused by mutations in the gene encoding CFTR, an 
epithelial anion channel (Ashlock et al 2011). CFTRF508 is the most common CF-
associated mutation, which accounts for about 70% of CF alleles (101). CFTRF508 
is retained in the ER and rapidly degraded through the ERAD pathway, which 
prevents its trafficking to the plasma membrane (Ostedgaard et al 2007). RMA1, an 
ER-anchored RING finger E3 is involved in ERAD of CFTRF508 (Younger et al 
2006). gp78 may act as an E4 to extend the polyubiquitin chain that has been 




interaction of CFTRF508 with p97/VCP, presumably to increase CFTRF508 
retrotranslocation. Harnessing gp78-mediated ERAD via knockdown of p97/VCP or 
overexpression of gp78 dominant negative mutant rescues CFTRF508 from ERAD 
and increases its trafficking to cell surface and partially restores its channel function 
(Vij et al 2006). By contrast, Hrd1 inhibits CFTRF508 degradation by acting as an 
E3 for gp78 (Ballar et al 2010). Knockdown of Hrd1 results in stabilization of gp78, 
and consequently increases in CFTRF508 degradation (Ballar et al 2010). Both 
p97/VCP and Derlin1 are critical components of the CFTRF508 degradation 
machinery. Small VCP/p97-interacting protein (SVIP) is known to sequester 
p97/VCP and Derlin1 away from gp78 to form an ERAD-inactive complex (Ballar et 
al 2007) (Fig. 3 C). It was shown that overexpression of SVIP leads to accumulation 
of CFTRF508 (Ballar et al 2010), supporting the idea that gp78 targets CFTRF508 
for degradation.  
gp78 is widely involved in degradation of neurodegenerative disease proteins. 
This function is unlikely to be specific for gp78, since Hrd1 also acts in the same 
spectrum of neurodegenerative disease proteins (Yang et al 2010, Ying et al 2009, 
Yang et al 2007, Ying et al 2011). Therefore, gp78 and Hrd1 probably recognize 
these mutant proteins by a quality control mechanism, although the mechanism of 
substrate recognition by these two E3s may be different. Polyglutamine expansion in 
huntingtin (htt) protein induces Huntington’s disease (HD) although the mechanism 
remains uncertain.  Some insights into the mechanism come from the discovery that 
mutant htt interacts with gp78 (Yang et al 2010). The HEAT repeats 2&3 of htt 




polyubiquitinated protein binding to gp78 and also sterically blocks gp78 interaction 
with p97/VCP. These effects of htt negatively regulate the function of gp78 in ERAD 
and are aggravated by polyglutamine expansion. Paradoxically, gp78 is still able to 
ubiquitinate and facilitate degradation of htt proteins with expanded polyglutamine. 
When mutant htt accumulates and aggregates, it also impairs the function of 
p97/VCP-Ufd1-Npl4 in ERAD by sequestering them to its aggregates (Duennwald et 
al 2008). Therefore, it is not surprising that the impairment of ERAD by mutant htt 
proteins is associated with induction of ER stress (Yang et al 2010, Duennwald et al 
2008). We speculate that mutant htt accumulates and gradually aggregates in neurons 
during HD progression, probably because the rate of mutant htt degradation is slower 
than the rate of its production/accumulation. The inefficiency in degradation of 
mutant htt proteins would preoccupy E3 proteins like gp78 and Hrd1 that might 
typically engage in ERAD in a futile effort toward degrading mutant htt proteins. This 
nonproductive interaction would lead to an accumulation of misfolded proteins in the 
ER leading to ER stress.  
Hrd1 and gp78 are also involved in ubiquitination and degradation of mutant 
neuroserpin (Ying et al 2011), a secreted glycoprotein and a serine protease inhibitor 
of serpin family predominantly expressed in the neurons of the central nervous 
system (CNS) (Hastings et al 1997). The role of neuroserpin is largely unknown, but 
it has been suggested that neuroserpin plays a neuroprotective role and may be 
involved in regulation of the morphology of neuroendocrine cells and neurite 
outgrowth (Parmar et al 2002). Point mutations in the neuroserpin gene result in its 




which causes familial encephalopathy with neuroserpin inclusion bodies (Miranda et 
al 2004).  Recent studies demonstrate that overexpression of Hrd1 and gp78 reduces 
the mutant neuroserpin levels, whereas knockdown of either E3 stabilizes it 
(Duennwald et al 2008). Impairment of p97/VCP function also stabilizes neuroserpin 
and increases its aggregation. These results suggest that mutant neuroserpin is a bona 
fide ERAD substrate for both gp78 and Hrd1 (Ying et al 2011). Therefore, gp78 and 
Hrd1 may play a protective role against mutant neuroserpin-induced neuronal 
degeneration. Similarly, gp78 has been shown to promote degradation of mutant 
superoxide dismutase 1 (SOD1) and ataxin-3, two neurodegenerative disease proteins, 
respectively associated with familial amyotrophic lateral sclerosis and Machado–
Joseph disease/spinocerebellar ataxia type 3 (Ying et al 2009). The pathological 
common feature of these neurodegenerative disease proteins is their accumulation and 
aggregation in neurons during disease progression. gp78 and Hrd1 act as quality 
control E3s for these mutant proteins, which is another common feature. These 
commonalities may explain why ER stress has been increasingly recognized as a 
common pathogenic factor in various neurodegenerative diseases (Lindholm et al 
2006). It is likely that gp78 and Hrd1 protect neurons at the early stage of the diseases 
when disease proteins are not in aggregates. As the diseases progress, production of 
mutant proteins exceeds the degradation capacity of gp78 and Hrd1, which leads to 
accumulation and aggregation of the mutant proteins. The disease protein aggregates 
interact with gp78 and Hrd1 as well as p97/VCP and impair their functions in ERAD 




cytosolic misfolded proteins, such as mutant htt, SOD1 and ataxin-3, extend the 
territory of the role of gp78 and Hrd1 in quality control to cytosolic proteins. 
Other substrates of gp78 include ATZ and cholera toxin (CT). Mutations of α-1-
antitrypsin (AAT) lead to AAT protein retention in the ER and deficiency of 
circulating AAT. Accumulation of mutant AAT in the ER causes severe liver injuries, 
such as neonatal hepatitis, juvenile cirrhosis and hepatocellular carcinoma (Perlmutter 
et al 2002). gp78 was shown to ubiquitinate and facilitate degradation of ATZ, the 
classic deficiency variant of circulating AAT having a Z mutation (Glu 342 Lys) 
(Shen et al 2006). Cholera toxin (CT) is the virulence factor produced by Vibrio 
cholera. It is transported from the cell surface to the ER lumen where the catalytic 
CTA1 subunit is retrotranslocated to the cytosol to induce pathological water 
secretion. Although CTA1 is not degraded after retrotranslocation, gp78 and Hrd1 
were shown to cooperate with Derlin1 and the ER luminal chaperone protein disulfide 
isomerase (PDI) to facilitate CTA1 retrotranslocation, suggesting that ubiquitination 

















Comments (substrate) References 
ApoB-100 gp78 A key protein component of LDL Stapf et al 2011, 
Liang et al 2003, 
Fisher et al 2011, 
Fisher et al 2008 
HMG-CoA 
reductase 
gp78 A rate-limiting enzyme in 
cholesterol biosynthesis 
Song et al 2005, 
Goldstein  et al 
2006, Sever et al 
2003, Cao et al 
2007 
Insig1 gp78 Regulator of cholesterol synthesis Song et al 2005,, 





Liver cytochrome P450 enzymes Kim et al 2010, 
Wang et al 2011 
KAI1 gp78 Tumor metastasis suppressor Tsai et al 2007, 





The most common mutation in 
cystic fibrosis transmembrane 
conductance regulator (CFTR) 
causing cystic fibrosis  
Morito et al 2008, 
Younger et al 






The Huntington’s disease protein Yang et al 2010, 





A mutant serine protease inhibitor 
causing familial encephalopathy 
with neuroserpin inclusion bodies 
Ying et al 2011 
Mutant 
SOD1 
gp78 A mutant antioxidant enzyme 
causing familial amyotrophic 
lateral sclerosis  
Ying et al 2011 
Ataxin-3 gp78 A mutant deubiquitinating enzyme 
causing Machado–Joseph 
disease/spinocerebellar ataxia type 
3 
Ying et al 2011 
ATZ gp78 Z variant of -1-antitrypsin (ATZ) 
causing deficiency in circulating 
-1-antitrypsin 





The virulence factor produced by 
Vibrio cholera requires 
retrotranslocation to exert its 
cytotoxicity 











Validated Direct vs. 
Indirect 
interaction 
with gp78  
Function References 
gp78 Hrd1p Yes Direct, via 
OS 
gp78 oligomerization 
required for gp78 E3 
activity 
Li, et al 
2009 
Ube2g2 Ubc7p Yes Direct, 
with 
G2BR  
Cognate E2 for gp78  Fang et al 
2001 
Derlin1 Der1p Yes  Unknown Substrate recruitment Ye et al 
2004, 
Lilley et al 
2004 




Zhong et al 
2004 
Ufd1 Ufd1p Yes Direct Cofactor for gp78 E3 
activity towards 
HMG-CoA reductase 
Cao et al 
2007 
Npl4 Npl4p Yes Unknown Forms a complex 
with p97/VCP in 
gp78-mediated 
ERAD  
Ballar et al 
2011, 
Soetandyo 
et al 2010, 











Li et al 
2005, Li et 
al 2008 





Involved in recruiting 
p97/VCP and 
ubiquilin to ERAD 
complex  
Liang et al 
2006 
 





Binds the proteasome 
and delivers the 
misfolded protein to 
proteasome 
Liang et al 
2006 
 
Bag6 Unavailable Yes Unknown Associates with gp78, 
maintains 
polypeptide solubility 
and may escort 
substrates to the 
proteasome 








Validated Direct vs. 
Indirect 
interaction 
with gp78  
Function References 
UbxD8 Unavailable Yes Unknown Unknown Mueller et 
al 2008 
Herp Usa1p Yes Unknown Unknown Schulze et 
al 2005 
SPFH2 Unavailable Yes Unknown Unknown Yo et al 
2011 
TMUB1 Unavailable Yes Unknown  Bridges SPFH2 to 
gp78 in ER 
membrane  
Yo et al 
2011 
VIMP Unavailable Yes Unknown Recruits p97/VCP to 
ER membrane 






















4.3  Regulation of gp78-mediated ERAD  
4.3.1  Regulation of gp78-mediated ERAD by autoubiquitination 
The function of gp78 in ERAD is subject to multilayered regulations. One of the 
most direct regulations is to modulate the levels of gp78 expression. ERAD prevents 
protein accumulation through elimination of misfolded proteins from the ER. When 
misfolded proteins fail to be removed efficiently by ERAD, accumulation of them 
will result in ER stress, which activates UPR. UPR upregulates transcription of 
ERAD components including E3 ubiquitin ligases (Travers et al 2000). We have 
demonstrated that tunicamycin-induced UPR increases the expression of gp78 mRNA 
(Chen, Z, Du, S and Fang, S, unpublished data).  In addition, acute ER stress 
enhances ERAD by stabilizing gp78 protein (Shen et al 2007). This is achieved by 
suppressing gp78 autoubiquitination. Autoubiquitination of gp78 targets itself for 
degradation by the proteasomes. Inhibition of E3 autoubiquitination may be a general 
mechanism by which cells rapidly respond to acute accumulation of misfolded 
proteins in the ER. Hrd1 exhibits the same response to that of gp78. This 
posttranslational response to boost ERAD activity is not limited to E3 ubiquitin 
ligases. For example, it has been reported that UPR boosts glycoprotein ERAD by 
suppressing the proteolytic downregulation of ER ManI. Stabilization of ER ManI 
protein enhances mannose processing, thereby facilitating ERAD (Termine et al 
2009). Thus, UPR enhances gp78-mediated ERAD at both the transcriptional and 
posttranslational levels.  




The crosstalk between E3 ubiquitin ligases has been shown to be involved in 
regulation of the ubiquitination activity of gp78 during ERAD (Ballar et al 2010, 
Shmueli et al 2009). gp78 is a substrate for the Hrd1 ubiquitin ligase (Ballar et al 
2010, Shmueli et al 2009). Autoubiquitination of gp78 requires its functional RNIG 
finger while the ubiquitination of gp78 by Hrd1 is solely dependent on the RING 
finger activity of Hrd1 but not on that of gp78 ( Shmueli et al 2009). The regulation 
of gp78 by Hrd1 is underscored by the observation that gp78 is stabilized in Hrd1 
knockdown cells and embryonic fibroblasts of Hrd1 homozygous knockout mice 
(Syvn
-/-
) ( Shmueli et al 2009). An interesting question is how the cells determine 
when and to what extent gp78 is regulated by autoubiquitination or Hrd1. 
4.3.3  Regulation of gp78-mediated ERAD by SVIP 
The function of gp78 is also regulated at the step of retrotranslocation. This 
regulation is mediated by the SVIP (Ballar et al 2007). SVIP does not have 
transmembrane domain and is localized to the ER membrane through myristoylation. 
SVIP contains a well-conserved VIM that competes with gp78 for binding to 
p97/VCP leading to interruption of gp78-p97/VCP interaction. Moreover, SVIP in 
fact sequesters p97/VCP and Derlin1 away from gp78. Derlin1 is a substrate-
recruiting protein for gp78. As expected, SVIP also inhibits the ubiquitination of the 
gp78 substrate, CD3. Thus, dependent on the relative levels of gp78 and SVIP, 
p97/VCP and Derlin1 can either form an ERAD-inhibitory complex with SVIP or an 
ERAD-active complex with gp78. Therefore, SVIP regulates gp78-mediated ERAD 




might not be limited to gp78-mediated ERAD, since p97/VCP is a converging point 
for probably all ERAD pathways (Fig. 3). 
In addition to its role in ERAD, SVIP is also a regulator of the autophagy 
pathway. As an ERAD inhibitor, SVIP facilitates autophagy by promoting LC3 
lipidation, enhancing p62 expression, sequestration of polyubiquitinated proteins to 
autophagosomes and increasing starvation-induced degradation of LC3II and p62 
proteins (Wang et al 2011). The opposite roles of SVIP in ERAD and autophagy may 
be important mechanisms by which cells handle ER stress. It was shown that ER 
stress causes an early downregulation of the SVIP protein and prolonged ER stress 
markedly increases SVIP protein levels. We speculate that when SVIP is 
downregulated, gp78 is upregulated, which leads to increases in ERAD activity. 
Prolonged ER stress causes a significant accumulation and aggregation of misfolded 
proteins in the ER, and ERAD is expected not to be effective under these conditions.  
Thus, prolonged ER stress upregulates SVIP to enhance autophagic removal of 
aggregated proteins from the ER. Therefore, SVIP may be a switch from ERAD to 
autophagy during the course of ER stress. 
5  ER stress and its association with lipid metabolism in the 
liver 
The unfolded protein response (UPR) activated by ER stress has been associated 
with the pathogenesis of many diseases, including diabetes mellitus due to 
insufficient insulin function, viral infections that require a large number of membrane 




proteins, and cancer, which is characterized by hypoxia, a disturbed oxidative 
environment within the ER (Lin et al 2008).  
Recently, the roles of ER stress and the UPR in hepatic steatosis have been 
under extensive study. First, the liver, as well as several other tissues, such as the 
pancreas, plasma, salivary gland, and mammary gland, are characterized by the 
expression of a large number of secretory proteins. Interestingly, in these tissues, it is 
common to observe high expression levels of chaperones or ERAD components 
under physiologic conditions. This indicates high levels of ER stress and a protective 
mechanism for the UPR. The reason for this could be explained by the fact that the 
liver is rich in rough ER, an important organelle for the proper folding of secretory 
proteins, calcium storage, and lipid and cholesterol synthesis, making the ER in the 
liver susceptible to an overload of misfolded proteins.  
5.1  ER stress in the liver 
In general, factors that trigger ER stress include, but are not limited to, free fatty 
acids, alcohol abuse, alcohol-induced toxic acetaldehyde production, alcohol-induced 
cytokine production, alcohol-induced toxic homocysteine, oxidative stress, 
perturbations of calcium or iron homeostasis, alterations of S-adenosylmethionine to 
Sadenosylhomocysteine ratio, and abnormal epigenetic modifications, glucosamine, 
lipogenic diet, glucose starvation, hypoxia, cell differentiation, protein 
overproduction, diabetes, obesity, cancer, inflammation, virus infection, and 
chemicals such as glycosylation inhibitors, reductive agents, antibiotics, anticancer 
agent, and so on. (Ji 2012). 




5.2.1  Sources of lipids in non-alcoholic and alcoholic hepatic steatosis 
In general, several factors can trigger hepatic steatosis, such as insulin resistance, 
alcohol abuse, drug abuse, smoking, virus infection and genetic diseases. However, 
the sources of triglycerides are important factors in both non-alcoholic and alcoholic 
fatty livers. De novo lipogenesis (DNL, about 25%), dietary fatty acids (DFA, about 
15%), plasma nonesterified fatty acid (NEFA, about 60%) from lipolysis of adipose 
tissue are three main sources of accumulation of triglycerides (Donnelly et al 2005).  
In terms of the mechanism, increased de novo synthesis, increased uptakes and 
decreased fatty acids oxidation and decreased export all contribute to accumulation of 
triglyceride. (Donnelly et al 2005). First, increase of triglyceride synthesis is one of 
the major causes of hepatic steatosis. This could occur by increased availability of 
glycerol and fatty acids. Second, increased uptakes, for example, prolonged exposure 
of free fatty acid results in accumulation of triglycerides, hepatic steatosis, and 
induction of ER stress in McA-RH7777 liver cells (Ota et al 2008). In addition to this, 
free fatty acids are toxic to cells. Indeed, free fatty acid has been shown to induce ER 
stress and apoptosis in pancreatic β cells and liver cells (Kharroubi et al 2004., Wei et 
al 2006., Wang et al 2006.). Third, reduced fatty acid oxidation contributes to 
development of fatty liver diseases. For example, accelerated fatty acid oxidation in 
other tissues, such as muscle, can reduce hepatic steatosis after 24 h fast in SJL/J 
mice (Guan et al 2009.). Fourth, decrease of export worsen the lipid accumulation. 
For example, excess accumulation of hepatic lipid may inhibit hepatic apolipoprotein 
B100 secretion, which worsen the hepatic steatosis (Ota et al 2008). It was also 




stress and inhibition of ER stress that restored OA-stimulated ApoB secretion after 
prolonged OA infusion (Ota et al 2008).  
Upregulation of several genes involved in lipid metabolism also contributes to 
alcoholic hepatic steatosis in response to alcohol exposure. Mice exposed to chronic 
alcohol feeding showed hepatic steatosis in which many genes are upregulated (Yin et 
al 2007). These genes are involved in (i) transport of glucose into hepatocytes and 
glycolysis to produce acetyl-CoA for fatty acid de novo synthesis, (ii) fatty acid 
transporters such as CD36, Slc27a1 and Slc27a4, and de novo synthesis through 
activation of Srebp1c pathway, (iii) fatty acid esterification to triglycerides, (iv) 
cholesterol transport, rate-limiting enzyme of de novo cholesterol synthesis, HMGCR 
through activation of Srebp2 pathway and bile acid synthesis (Yin et al 2007). 
5.2.2  Role of insulin resistance in development of non-alcoholic hepatic steatosis 
Regulation of insulin levels also plays an important role in the development of 
non-alcoholic fatty livers. First, insulin resistance might stimulate delivery of glucose 
and fatty acids to liver and adipose tissues, where excess of glucose is converted into 
fatty acids and triglyceride during glycolysis and lipogenesis and they are stored in 
the form of glycogen and lipids respectively. Second, insulin resistance might inhibit 
glucogeneogenesis and glycogenolysis. Third, insulin inhibits lipolysis in the liver, 
but insulin resistance in adipocytes might reversely overstimulate lipolysis (Yang et 
al 2009), leading to an increase in the plasma non-esterified fatty acid flux (Lewis et 
al 2002., Zhou et al 2009., Sanyal et al 2001). Fourth, insulin stimulates fatty acid 
synthesis by upregulation of its transcripts, enhancing processing of mature SREBPs 




Hegarty et al 2005). Last but not the least, clinical studies showed that treatment of 
diabetic patients with drugs to improve insulin sensitivity successfully, in part, 
reduced the fat accumulation in the liver (Polyzos et al 2009). 
5.2.3  Acetaldehyde affects lipid metabolism  
Acetaldehyde is toxic to hepatocytes and may play a critical role in development 
of fatty liver diseases. Acetaldehyde, an ethanol intermediate metabolite, is toxic to 
cells if not further metabolized. Moreover, acetaldehyde was proposed to activate  
(peroxisome proliferator-activated receptor α) PPARα, a key nuclear hormone 
receptor that when activated, forms heterodimer with retinoid X receptor (RXR), 
binds to peroxisome proliferator response element of genes involved in the fatty acid 
oxidation pathways, and activates their transcription (Crabb et al 2006). Here it is 
worth pointing out that posttranslational modification of PPARα or RXR or its ligand 
by acetaldehyde, a highly reactive chemical to amino group of proteins, might 
underlie its molecular mechanism. Not surprisingly, PPARα knockout mice displayed 
impaired fatty acid oxidation, and accumulation of lipid with fasting, accompanied 
with hypoglycemia and increased serum free fatty acids (Le May et al 2000). 
Consistent with this, evidence showed that treatment of PPARα agonists reduced 
alcoholic fat accumulation in mice fed with ethanol (Marche et al 2011).  
5.2.4  Cytokine production triggers development of hepatic steatosis 
Ethanol-induced cytokine production by Kupffer cells, e.g. TNFα, seems to play 
a critical role in development of alcoholic liver diseases. A detailed review on the 
roles of Kupffer cells, TNFα, and other factors, such as adiponectin, osteopontin, 




has been reviewed (Crabb et al 2006). These evidences of cytokine production in the 
development of alcoholic fatty livers include but are not limited to the following 
aspects. First, mice depleted of Kupffer cells showed resistance to ethanol-induced 
liver injury (Adachi et al 1994). Second, cytokines result in imbalance of calcium 
homeostasis through inhibition of SERCA (sarcoplasmic/endoplamic reticulum Ca
2+
-
dependent ATPase) pump expression in the ER and thus induce ER stress in 
pancreatic β-cells (Cardozo et al 2005). Third, anti-TNFα antibody treatment 
attenuated hepatic inflammation and necrosis observed in ethanol-fed rats without 
improvement of hepatic steatosis (Limuro et al 1997). Fourth, clinically, plasma 
inflammation has been shown to be associated with hepatic steatosis and serum 
adipokine levels are proposed to be a marker of nonalcoholic fatty liver disease. 
(Lemoine et al 2009., Tarantino et al 2009).  
5.2.5  Other pathways involved in regulation of lipid metabolism 
The AMP-activated protein kinase (AMPK) pathway is involved in regulation of 
lipid metabolism in liver. AMPK signaling inhibits ACC and HMG CoA reductase 
and thus reduces fatty acid and cholesterol synthesis respectively. Upon alcohol 
feeding, AMPK activity is reduced, leading to reduced level of phosphorylated acetyl 
coenzyme A carboxylase a (ACC1) and increased ACC1 activity, and consequently 
increased fatty acid synthesis (Davies et al 1992).  
Estrogens also play a role in regulation of hepatic cholesterol. It is believed that 
females are more protected from hypercholemia-related diseases because of the 
hypolipidemic estrogens they produce (Farhat et al 1996., Bär et al 1997).  




Recently, more and more studies are focusing on the question of whether ER 
stress plays a direct and sufficient role in the development of fatty livers. Indeed, 
tunicamycin treatment in zebrafish larvae induces the upregulation of ER stress 
markers in the liver and mimics the hepatic steatosis seen in the hi559 mutant (Thakur 
et al 2011). In humans, the attenuated expression of ER stress markers, such as BiP, 
spliced X-box binding protein 1 (XBP1), phosphorylated α-subunit of eukaryotic 
translation initiation factor 2 ( eIF2α) , and JNK1, was observed in the liver, adipose 
tissue, and skeletal muscle of obese subjects after weight loss (Gregor et al 2009). In 
a mouse model of type 2 diabetes, the treatment of obese and diabetic mice with the 
chemical chaperones 4-phenyl butyric acid and taurine-conjugated ursodeoxycholic 
acid reduces ER stress, restores insulin sensitivity, resolves fatty liver disease, and 
enhances insulin action in the liver, muscle, and adipose tissue (Ozcan et al 2006). 
Adipose triglyceride lipase knockout mice show protection from ER stress in 
response to tunicamycin treatment, along with increased lipid accumulation in the 
liver, probably due to the inability to produce free fatty acids (Fuchs et al 2012). All 
together, these studies suggest a causal role for ER stress in hepatic steatosis. 
The molecular mechanism of alcohol-induced hepatic ER stress is complicated 
and remains largely unknown. Some of the factors that trigger alcohol-induced 
hepatic ER stress include toxic acetaldehyde and homocysteine, oxidative stress, 
perturbations of calcium or iron homeostasis, the alteration of the S-
adenosylmethionine to S-adenosylhomocysteine ratio, and abnormal epigenetic 




An open question that remains to be further investigated is why ER stressed cells 
display lipid accumulation. It is believed that ER stressed cells undergo not only an 
increased protein load, but also an expansion of the lipid components of their 
membranes. The expansion of the ER might play a beneficial role in terms of 
reducing the protein load to the ER lumen.  
How ER stress results in hepatic steatosis also remains poorly understood. 
Several studies have shown that ER stress induces the activation of SREBPs, master 
regulators of de novo lipid biosynthesis (Colgan et al 2007., Lee et al 2004). However, 
this does not provide a detailed mechanism and does not clarify whether and how the 
UPR pathway is involved in the development of hepatic steatosis. There are 3 
branches of the UPR and each arm seems to play a role in hepatic lipid metabolism in 
a particular way (Fig. 4).  
5.4  Activation of unfolded protein response by ER stress plays a role 
in hepatic steatosis 
5.4.1  Role of the IRE1-XBP1 pathway in hepatic steatosis 
Overexpression of the splicing-form of Xbp1 is sufficient to induce 
phosphatidylcholine biosynthesis, suggesting a dual role for XBP1 and a link between 
the UPR and lipid metabolism (Sriburi et al 2004). On the other hand, conditional 
knockout of Xbp1 in the liver caused hypotriglyceridemia and hypocholesterolemia 
due to defects in de novo lipogenesis without affecting protein secretory functions 
(Lee et al 2008). This also indicates that the dual functions of XBP1 in both 




The exposure of mice with a liver-specific deletion of inositol-requiring protein 
1α (Ire1α) to tunicamycin causes the upregulation and nuclear localization of 
CCAAT/-enhancer-binding protein homologous protein (CHOP), which was 
proposed to interfere with the function of C/EBPα (Rutkowski et al 2008). CHOP is a 
novel developmentally regulated nuclear protein that dimerizes with the transcription 
factors CCAAT enhancer-binding protein (C/EBP) and the full-length isoform of the 
C/EBPβ protein (LAP) and functions as a dominant-negative inhibitor of gene 
transcription (Rutkowski et al 2008).  
5.4.2  Role of the PERK-eIF2α pathway in hepatic steatosis 
The inhibition of the doublestranded RNA-activated protein kinase-like ER 
kinase (PERK)-eIF2α arm of the UPR pathway through Growth Arrest and DNA 
Damage-inducible 34 (GADD34), a eIF2α-specific phosphatase, causes low glycogen 
and susceptibility to fasting hypoglycemia in lean mice, and resistance to hepatic 
steatosis in animals fed a high-fat diet. This phenomenon is correlated with the 
reduced expression of the adipogenic nuclear receptor PPARgamma and C/EBPα and 
C/EBPβ (Oyadomari et al 2008). Challenging mice that express dominant-negative 
eIF2α (S51A) in the liver specifically with tunicamycin caused attenuated lipid 
accumulation in the liver (Oyadomari et al 2008). This attenuated lipid accumulation 
could be explained by the observed reduction in the expression of C/EBPα 
(Oyadomari et al 2008). On the other hand, the deletion of PERK resulted in the 
decreased expression of lipogenic enzymes and reduced lipid content in the mouse 
mammary gland (Bobrovnikova-Marjon et al 2008). The suppression of 




observed the attenuated translation of ApoB-100 via the PERK pathway in 
glucosamine treated HepG2 cells, leading to the suppressed secretion of ApoB-100 
(Qiu et al 2009).   
5.4.3  Role of the ATF6 pathway in hepatic steatosis 
Activating transcription factor 6 (ATF6) seems to play pathological and 
protective roles in chronic and acute ER stress-induced hepatic steatosis respectively. 
Acute treatment of Atf6 knockout mice with tunicamycin treatment causes hepatic 
steatosis, most likely due to the increase of SREBP1 target genes, reduced oxidation 
of fatty acids, and decreased secretion of ApoB-100 (Yamamoto et al 2010). 
Consistent with this, morphorlino knockdown of Atf6 showed increased expression 
levels of ER stress markers in response to acute tunicamycin treatment and thus 
protected against hepatic steatosis in zebrafish embryos (Cinaroglu et al 2011). On 
the other hand, morphorlino depletion of Atf6 displayed reduced expression levels of 
ER stress markers in response to chronic tunicamycin treatment and thus protect 
against hepatic steatosis in zebrafish embryos (Cinaroglu et al 2011). The 
pathological role of ATF6 is evidenced by the observation that overexpression of an 
active form of ATF6α stimulates fatty acid synthesis (Bommiasamy et al 2009).  
5.4.4  Roles of some other players of the UPR pathway in hepatic steatosis 
Despite each arm of the UPR functioning in hepatic lipid metabolism under 
physiologic and high-fat diet conditions, whether ER stress plays a direct role in 
hepatic lipid metabolism remains unknown (Rutkowski et al 2008). Studies on some 




Importantly, the overexpression of BiP, the ER molecular chaperone upregulated 
during activation of the UPR, protects against the hepatic steatosis induced by insulin 
and ER stress in ob/ob mice (Kammoun et al 2009). This prevention, at least in part, 
works through the inhibition of SREBP-1c activation, reducing the expression of 
SREBP-1c target genes, and thus reducing the levels of triglyceride and cholesterol 
(Kammoun et al 2009). On the other hand, it was shown that the liver specific 
deletion of BiP resulted in ER stress, apoptosis, fat accumulation, sensitivity to 
alcohol, high-fat diet, and toxin-induced hepatic disorders (Ji et al 2011). In this study, 
it was shown that the molecular chaperone 4-phenylbutyrate can attenuate the fat 
accumulation that ensues after the above treatments (Ji et al 2011). CHOP, another 
important transcription factor activated by ER stress, was also consistently shown to 
function in the regulation of hepatic steatosis. CHOP knockout mice showed reduced 
apoptosis despite the appearance of hepatic steatosis upon ethanol feeding (Ji et al 
2005).  
Despite these studies, whether the activation of the UPR induced by ER stress 
plays a direct role in hepatic lipid accumulation is not completely understood and 
requires further investigation. Studies on the role of downstream effectors of the UPR, 
such as E3 ubiquitin ligases, on the regulation of hepatic protein homeostasis and 
lipid metabolism might provide useful insight.  
5.4.5  Role of the ubiquitin-proteasome system in the regulation of key regulators 
of lipid metabolism 
Several proteins involved in lipid metabolism, such as HMGCR, ApoB-100, 




secretion of ApoB is highly regulated. Apolipoproteins are synthesized in both the 
rough and smooth ER (Glaumann et al 1975). Their secretion is largely regulated at 
the translational and posttranslational level rather than at the transcriptional level 
(Ginsberg et al 1995). 
 The mature form of SREBP can be regulated by the ubiquitin-proteasome 
system (Hirano et al 2001). Glycogen synthase kinase 3 (GSK-3) phosphorylates 
SREBP, leading to a conformational change in SREBP, and thus promotes the 
binding of SREBP to the SCFFbw7 ( SKP1-cullin-1-F-box complex that contains 
FBW7 as the F-box protein) E3 ubiquitin ligase, which targets it for subsequent 26S 
proteasomal degradation (Sundqvist et al 2005., Punga et al 2006). This suggests a 
critical role for signal transduction by SREBP in cholesterol metabolism 



























































Fig. 4. Role of the ER stress-activated unfolded protein response (UPR) in 
hepatic steatosis.  
PERK phosphorylates eIF2α, inhibits protein synthesis, including that of 
APOB100, and thus causes reduced secretion of triglycerides in the liver. The 
phosphorylation of eIF2α increases the expression of adipogenic nuclear PPARγ, 
C/EBPα and C/EBPβ. IRE-1 inhibits the nuclear localization of CHOP, which is 
believed to interfere with the transcription factors C/EBPα and C/EBPβ in the 
nucleus. C/EBPα and C/EBPβ induce lipogenesis through another transcription 
factor PPARγ. XBP1 might have a role in inducing lipogenesis that is independent 
of the UPR pathway. ATF6 induces hepatic steatosis probably though the 
increased expression of SREBP1 target genes, reduced oxidation of fatty acids, 
and decreased secretion of ApoB-100. ATF6 might also function to protect against 





6.  Zebrafish as a model for the study of hepatic ER stress 
and lipid metabolism 
The zebrafish has become a popular model in biomedical research for studying 
lipid metabolism, fatty liver diseases, and tumorigenesis. Originally, the zebrafish 
was used as a model for liver development and recently it has been gaining popularity 
in the fields of cancer research, lipid metabolism in the liver, and lipid transport in the 
circulation system. For example, the zebrafish was proven to be an important and 
popular model in cancer research (Feitsma H & Cuppen E, 2008). Histological studies 
showed that zebrafish tumors resemble many types of human tumors. Moreover, 
several well-established tools, such as the high throughput screening of oncogenes, 
forward genetic screening of tumor suppressors, transplantation of human tumor cells, 
and the generation of transgenic fish that express human oncogenes, have rendered 
the zebrafish especially useful in oncology. 
There are several advantages of using the zebrafish as a model system in lipid 
metabolism. First, the metabolic pathways of zebrafish, mice, and humans are 
relatively conserved (Hölttä-Vuori et al 2010). 
Second, many relevant mutant zebrafish lines are available. These mutants might 
either display resistance to alcohol-induced hepatic steatosis or more severe fatty liver 
diseases, and will be useful tools for studying the mechanism of the development of 
hepatic steatosis. Moreover, chemical screening based on a defined genetic 
background was shown to be a promising approach for identifying chemical 




such as immunohistology, in situ hybridization, and other morphological analyses can 
be used to score phenotypes.  
Third, the zebrafish is a good model for the high-throughput screening of drugs 
for obesity treatment. It has been shown that simple staining of fat in live transparent 
zebrafish embryos using Nile red containing media might be a promising tool for 
screening anti-obesity drugs (Jones et al 2008).  
Fourth, the transparency of the zebrafish during early embryonic development 
makes it an excellent model for adipocyte research. One can use in vivo imaging 
analyses to study adipocyte development and the formation of adipose tissue and can 
directly visualize neutral lipid droplets with Nile red in the live animal in real time 
(Flynn et al 2009). In addition to Nile red, another useful dye is BCθ, a theta-toxin 
produced by Clostridium perfringens, which when conjugated with biotin and avidin-
conjugated fluorescent dyes is more stable for fluorescent microscopy as compared 
with conventional filipin staining because it shows less photobleaching (Reid et al 
2004). This could be especially useful for monitoring lipid metabolism in real time in 
the live animal. Another sensitive fluorescent cholesterol, BODIPY-cholesterol, was 
used to visualize sterol movement in living cells and organisms (Hölttä-Vuori et al 
2008). Using this technique and others, another group showed that the zebrafish is a 
good model to detect plaques in live animals. Confocal microscopy can detect 
vascular lipid accumulation in adult zebrafish fed with a high-cholesterol diet 
supplemented with a fluorescent cholesteryl ester. Lipid accumulation was found to 




that the zebrafish is a good model for studying the development of atherogenesis in 
vivo (Stoletov et al 2009).  
Fifth, easy alcohol exposure makes the zebrafish a good model for studying 
alcoholic fatty livers. The exposure of zebrafish embryos to alcohol at early stages 
causes phenotypes that mimic fetal alcohol spectrum defects (FASD). 
Supplementation with cholesterol rescues the phenotypes caused by impaired 
hedgehog signal transduction (Li et al 2007). Another study showed that 45 h ethanol 
exposure causes developmental defects, such as delayed development, axial 
malformation, cyclopia, otolith defects, pericardial edema, yolk sac edema, and axial 
blistering in zebrafish and the internal ethanol concentration reached about 340 mM. 
Exposure to acetaldehyde, a toxic intermediate product of ethanol metabolism if not 
catalyzed, caused similar phenotypes (Reimers et al 2004).  
Sixth, direct knockout models in zebrafish have become more and more feasible. 
Heritable targeted gene disruption using designed zinc-finger nucleases has been 
successfully accomplished (Doyon et al 2008). More recently, transcription activator-
like (TAL) effector nucleases (TALENs), which contain a TAL effector DNA binding 
domain and a FokI nuclease cleavage domain, were shown to be a more specific way 






Chapter 2: Functional Characterization of gp78 during 
Early Embryonic Development in Zebrafish 
1.  Abstract 
Mammalian gp78 is an E3 ubiquitin ligase that is anchored at the membrane of 
the ER. It regulates protein homeostasis by polyubiquitinating and targeting proteins 
for proteasomal degradation under both physiologic and stressed conditions. To test 
its role in vivo, we analyzed the gross embryonic morphology of zebrafish embryos in 
which gp78 was knocked down using morpholinos and of transgenic zebrafish 
overexpressing wild-type gp78 or dominant-negative gp78. We show that gp78 is 
highly conserved among vertebrates. Zebrafish gp78, like human gp78, can colocalize 
with mouse MmUBC7 in HeLa cells. In vitro ubiquitination assays confirmed that 
zebrafish gp78 indeed is an E3 ubiquitin ligase. Although gp78 was maternally and 
constitutively expressed during embryonic development, with relatively high 
expression levels in several tissues, such as the liver and brain, knockdown of gp78 or 
overexpression of wild-type or dominant-negative gp78 did not result in 
developmental defects, suggesting a compensation by other E3s during embryonic 
development.  
2.  Introduction 
ER-associated protein degradation (ERAD) is critical for the maintenance of ER 
protein homeostasis. Proteins destined for the secretory pathway must be properly 
folded before transportation to their final, functional destinations. The quality of 




achieves the proper folding of the majority of proteins using unique enzymes and 
molecular chaperones, and retains misfolded and unassembled proteins in the ER 
(Ellgaard et al 2003). Misfolded proteins are recognized, retrotranslocated, 
polyubiquitinated, and then targeted for degradation by the 26S proteasome in the 
cytosol; a complicated process termed ER-associated protein degradation (ERAD) 
(Vembar et al 2008).  
ERAD plays a critical role in cell survival. It has been shown that the 
simultaneous loss of ERAD and UPR results in dramatic cell death (Travers et al 
2000). Furthermore, the overexpression of parkin, an E3 ubiquitin ligase, protects 
against cell death induced by ER stress (Imai et al 2000). All this evidence indicates 
an important role for ERAD in cell survival.  
Recently, we and several other groups showed that gp78, an E3 ubiquitin ligase, 
plays an important role in the regulation of physiological and pathological processes 
by targeting its substrates for proteasomal degradation (Chen, Du, and Fang 2011). 
gp78 was the first mammalian ER membrane-bound E3 ubiquitin ligase to be 
discovered that mediates the ubiquitination of unwanted proteins during ERAD (Fang 
et al 2001). It was originally isolated as a 78 kiloDalton (kDa) membrane 
glycoprotein from murine melanoma cells and as a tumor autocrine motility factor 
receptor, AMFR, mediating tumor invasion and metastasis (Nabi et al 1987, Silletti et 
al 1991, Nabi et al 1990). Recently, gp78 was reported to promote sarcoma metastasis 
and regulate cell proliferation by targeting a metastasis suppressor KAI1 for 
degradation (Tsai et al 2007, Joshi et al 2010). More importantly, the targeted 




lethality with aberrant hematopoiesis and increased apoptosis in the liver (Yagishita 
et al 2005). Consistent with this, the deletion of gp78 homolog, Hrd1 in 
Caenorhabditis elegans affected growth rate (Sasagawa et al 2007). However, in 
yeast, unlike in mice, the deletion of Hrd1p did not result in lethality (Bordallo et al 
1998). Importantly, deletion of gp78 ortholog, Hrdl-1, in C. elegans, did not affect 
growth rate (Sasagawa et al 2007). These led us to the question of whether gp78 is 
required for embryonic development. So far, there is no literature on gp78 knockout 
animal models. Thus, the in vivo function of gp78 remains largely unknown. Here we 
designed experiments to characterize gp78 in zebrafish and to determine its in vivo 
function during embryonic development. Surprisingly, the dysfunction of gp78 did 
not result in developmental defects. Our results indicate that other E3 ligases may 
compensate for the loss of gp78 in zebrafish. 
3.  Materials and Methods 
1) Maintenance of zebrafish  
Adult zebrafish were raised and maintained at the zebrafish facility of the 
Aquaculture Research Center, Institute of Marine and Environmental Technology as 
previously described (Li et al 2011). Briefly, the fish were maintained at 28 °C with 
14 h of light and 10 h of dark, in 8 gallon aquaria supplied with freshwater and 
aeration. 
2) Isolation of gp78 cDNA from zebrafish  
Total RNA was extracted from 5 days post fertilization (dpf) zebrafish larvae 
using Trizol reagent (Invitrogen, CA, USA). A rapid amplification of cDNA ends 




(Fermentas, MD, USA). Zebrafish gp78 cDNA was cloned from the 5’ RACE library 
using a 5’ GP78-P1 primer and a 3’ GP78-P2 primer that has a C-terminal myc tag 
sequence followed by the stop codon. The PCR products were purified and cloned 
into the pGEM-T easy vector to generate the pGEM-gp78 plasmid. 
GP78-P1, 5’- ATGCCTCTGCTGTTTCTGGAGCG-3’;  
GP78-P2, 5'-CTACAGATCCTCTTCAGAGATGAGTTTCTGCTCGAATGG- 
GGAAGGCTCCTGCCTCA-3’. 
3) Whole-mount in situ hybridization 
The gp78 antisense probe was synthesized using the pGEM-gp78 plasmid as a 
template. pGEM-gp78 was linearized with NcoI and transcribed with SP6 RNA 
polymerase. Whole-mount in situ hybridizations were performed as described (Du et 
al 2001).  
4) Synthesis of morpholino-modified antisense oligos for translation blockers 
The gp78 translation blocker morpholino (gp78-5’-UTR-MO) was made on the 
basis of the antisense sequence of the 5’-untranslated region (UTR). The gp78-5’-
UTR-MO (CAGTCCACACGTACAGCAGTCTTCT) was purchased from Gene 
Tools (Philomath, OR, USA) and used as described previously (Nasevicius & Ekker 
2000).  
The sequence of gp78-5’-UTR-MO, CAGTCCACACGTACAGCAGTCTTCT.  





To generate a DNA construct expressing myc-tagged gp78, the gp78 coding 
sequence with the myc tag sequence was re-amplified using BamHI-gp78-p1 and 




through blunt end ligation using the EcoRV cut sites in the vector. The insert was 
then released from the pBSSK-gp78 plasmid by NotI and BamHI digestion. The DNA 
insert of gp78 was then subcloned into the NotI and BamHI sites of the 
T2AL200R150G vector (Urasaki et al 2006), which contains an ef1α promoter, to 
produce the plasmid ef1α:gp78
myc
. gp78-R2M mutations were generated by using the 
QuickChange site-directed mutagenesis kit (Stratagene, CA, USA). All constructs 









 transgenic fish 
To generate transgenic fish, the constructs were co-injected with the Tol2 
transposase mRNA into zebrafish embryos at the 1-cell stage. Germ-line transgenic 
founders were screened by PCR by using DNA from 100 pooled F1 embryos at 24 
hours post ferilization (hpf). Adult F1 transgenic fish were identified by PCR by 
using DNA from caudal fin as previously described (Tan et al 2006). The expression 
of exogenous gp78 transcripts were detected by RT-PCR using primers IVS-E1E2-P1 
and gp78-I-P3.  
IVS-E1E2-P1 GATCCTGAGAACTTCAGGCTCCT 
Gp78-I-P3 TGTGCATGACCTCCACTGAGAAACT 
7) Morpholino and DNA microinjection in zebrafish embryos 
Morpholino antisense oligos were dissolved in Danieau buffer (Nasevicius & 




the 1- or 2- cell stage with 1–2 nL (5 or 10 ng) of morpholino (MO). 1–2 nL of DNA 
(100 ng/µL) was injected into zebrafish embryos at the 1- or 2- cell stage.  
8) Reverse Transcription (RT)-PCR 
Total RNA was isolated from zebrafish embryos at 0, 3, 6, 12, 14, 19, and 24 hpf 
and 2, 3, 4, 5, and 6 dpf with the Trizol reagent (Invitrogen). 1 μg of total RNA was 
used for the synthesis of cDNA using the first-strand cDNA synthesis kit (Fermentas). 
1 μL of synthesized cDNA was used for PCR reactions. 12.5 μL of PCR reaction 
solutions were used in DNA agarose gel electrophoresis. Primers and PCR cycles 
were listed in Table 3.  
9) Immunostaining of whole-mount fish embryos 
Immunostaining was carried out using whole-mount zebrafish embryos as 
described previously (Tan et al 2006) with an anti-myc antibody (90E10α, A7811; 
Sigma, MO, USA). The secondary antibody was a biotinylated anti-mouse IgG 
(Vector Laboratories, CA, USA). Signal was detected using the avidin-biotin-
peroxidase/diaminobezidine (ABC-DAB) assay (ABC, Vector Laboratories, 
Burlingame, CA). The embryos were photographed under an upright microscope 
(Leica MZ12, Heerbrugg, Switzerland) equipped with an Olympus DP70 Digital 
Microscope Camera (Olympus America Inc., NY, USA).  
10) Cell culture and immunostaining 
To produce a flag-tagged zebrafish gp78, the gp78 coding sequence with flag tag 
sequence was re-amplified using Hind III-gp78-p1 and BamH I-gp78-p2 primers. The 
amplified PCR product was subcloned to pFLAG-CMV6a vector through HindIII and 




MmUBC7 constructs were described previously (Chen et al 2006, Fang et al 2001). 
HeLa cells grown on slide glass were transiently co-transfected plasmids encoding 
flag-h-gp78 or flag-zf-gp78 with myc-MmUBC7. 24 h after transfection, cells were 
fixed in 4% paraformaldehyde for 30 min at 4 °C and blocked in 0.1 % saponin, 
0.1 % human serum albumin. The cells were labeled with mouse monoclonal anti-
FLAG antibody and rabbit monoclonal anti-myc antibody for 1 h following labeled 
with Alexa ® Fluor 488 conjugated goat anti-mouse IgG (H+L) and Alexa ® Fluor 
594 conjugated with goat anti rabbit IgG (H+L) for 1 h. Fluorescence microscopy was 







11) Western blot analysis 
Wild-type or MO-injected zebrafish embryos at 24 hpf (100 embryos each) and 
48 hpf (50 embryos each) were dechorionated manually and crushed gently to remove 
the yolk by triturating with a glass pipette. Embryos at 96 hpf (30 embryos each), and 
120 hpf (20 embryos each) were directly used for protein extraction. All embryos 
were solubilized in 200 μL sodium dodecyl sulfate (SDS) loading buffer (0.125 M 
Tris-Cl, pH 6.8; 4 % SDS; 20 % glycerol; 0.2 M dithiothreitol (DTT); 0.02 % 
bromophenol blue) containing phenylmethanesulfonyl fluoride ((PMSF), 1 mM) as a 
protease inhibitor. Samples (20 μL each) were vortexed, and the proteins were 
separated on a 10 % SDS-polyacrylamide gel electropheresis (PAGE) gel. Adult fish 
liver, brain, heart, pancreas, ovaries, and muscle were dissected from 3-month-old 




Dissected organs were homogenized in buffer consisting of 20 mM HEPES-KOH 
(pH 7.4), 100 mM KCl, 2 mM EDTA, 1 mM PMSF, 1 mM dithiothreitol, 10 μg/mL 
leupeptin, 1 μg/mL pepstatin A, and 1 % Triton X-100. 20–40 μg of liver samples 
were used in each lane. Proteins were electrophoretically transferred onto a 
polyvinylidene fluoride (PVDF) membrane (Immobilion-P; Millipore, MA, USA). 
Immunodetections were carried out by incubating the membrane with primary 
antibodies recognizing gp78 (1F1; Yang et al 2010) and γ-tubulin (1:2000; Sigma) 
followed by incubation with peroxidase-conjugated secondary antibodies.  
12) In vitro ubiquitination 
pET28a-gp78C was described previously (Yang et al 2010). To generate a 
pGEX-4T-gp78C construct that encodes GST-tagged cytosolic part of zebrafish gp78, 
primers BamHI-gp78C-P1 and XhoI-gp78C-P2 were designed. Expression and 
purification of 6×histidine (his)-taggged gp78C and GST-tagged-zf-gp78C were 








In vitro ubiquitination was performed as described (Li et al 2009). In brief, E1 
(60 nM), Ube2g2 (200 nM), ubiquitin (10 μM ) were incubated with gp78C (2 μg) in 
a 20 μl reaction system at 37 °C in buffers containing 25 mM Tris/HCl (pH 7.4), 2 
mM ATP, and 2 mM MgCl2. 2 μl of the reaction mix were sampled at indicated time  
and subjected to treatment with the same volume of 2×SDS sample buffern at 95 °C 
for 5 min. Ubiquitin (Ub) chains were detected by immunostaining with anti-ub 





1)  Isolation and characterization of zebrafish gp78 
Full-length gp78 cDNA was isolated from zebrafish 5 dpf larvae by RT-PCR. 
The PCR product encodes a protein of 620 amino acids that shares high sequence 
identity with gp78 from frog, mouse, and humans, suggesting that it is a gp78 
ortholog (Fig. 2). Zebrafish gp78 is predicted to have 5 N-terminal transmembrane 
domains and 5 other known domains in the cytosolic-tail (Fig. 5). Sequence 
comparison shows that all these domains are highly conserved among zebrafish, frog, 
mouse, and human (Fig. 2). Amino acid sequence comparison reveals that zebrafish 
and human gp78 have 94 %, 97 %, 81 %, 50 %, and 48 % identity for the RING, 
oligomerization site (OS), Cue, G2BR, and p97 binding domains (also named as 
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Fig. 5. Schematic of the domains of zebrafish gp78, and sequence alignment of 
gp78 between zebrafish and humans.  
The zebrafish gp78 contains 5 transmembrane domains (TMs) and 5 conserved 
domains in the cytosolic tail. The conserved cytosolic domains, really interesting 
new gene (RING) finger, oligomerization site (OS), coupling of ubiquitin to ER 
degradation (Cue) domain, Ube2g2-binding region (G2BR) and a p97/VCP-
interacting motif (VIM), are compared between zebrafish and human gp78. The 
TMs were predicted using TMHMM-2.0. Multiple sequence alignment was 





2)  E3 ubiqutin ligase activity of zebrafish gp78 
Since zebrafish contains all the conserved domains of mammalian gp78, we 
determined whether zebrafish gp78 is an E3 ubiquitin ligase. We assayed for ER 
colocalization by immunostaining and by in vitro polyubiquitination assays using 
recombinant proteins. The results showed that zebrafish gp78, like human gp78, 
colocalized with mouse MmUBC7 in HeLa cells (Fig. 6 A-B). To test whether 
zebrafish gp78 has an E3 ubiquitin ligase activity, we expressed and purified 
glutathione (GST)-tagged zebrafish gp78 cytosolic part (zf-gp78C-GST) and 6xhis-
tagged human gp78 cytosolic part (h-gp78C-his) (Fig. 6 C). In vitro ubiquitination 
assays using purified recombinant zf-gp78C-GST and  h-gp78C-his confirmed that 
zebrafish gp78 is indeed an E3 ubiquitin ligase that can promote the formation of 



















































































3)  Temporal and spatial expression of gp78 in zebrafish embryos  
Fig. 6. ER localization and E3 ubiquitin ligase activity of zebrafish gp78.  
(A, B) Flag-tagged zebrafish gp78 (flag-zf-gp78) and flag-tagged human gp78 
(flag-h-gp78) colocalize with myc-tagged mouse MmUBC7 by immunostaining 
using anti-flag or anti-myc antibodies in HeLa cells. (C) Recombinant His-tagged 
human gp78 (H-gp78C-his) and GST-tagged zebrafish gp78 (zf-gp78C-GST) were 
expressed and purified from E. coli. (D) In vitro ubiquitination showed that 
recombinant His-tagged human gp78 (H-gp78C-his) and GST-tagged zebrafish 




3)  Expression patterns of zebrafish gp78 
The temporal expression of gp78 was determined in zebrafish embryos by RT-
PCR (Fig. 7 A). gp78 transcripts were detected in fertilized eggs, suggesting that it 
was expressed maternally. The expression of gp78 remained constitutive at all 
embryonic and larval stages analyzed, from fertilization up to 6 dpf.  
To determine the spatial patterns of expression, we analyzed gp78 expression in 
zebrafish embryos by whole-mount in situ hybridization (Fig. 7 B–E). A 1125 base 
pair (bp) antisense probe complementary to the 3’ end of the gp78 RNA transcript 
was generated for in situ hybridization. In situ hybridization using the probe revealed 
expression in several tissues including the brain, eyes, liver, gut, and pancreas of 
zebrafish embryos at 4 dpf and 5 dpf (Fig. 7 B–E). Western blot analysis showed 
expression of gp78 in several of the tissues tested and a relatively high expression in 
the brain, liver, and ovary (Fig. 7 F). Similar expression patterns were found in 
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Fig. 7. Temporal and spatial expression patterns of gp78 in larval and adult 
zebrafish.  
(A) The gp78 transcript in zebrafish embryos was detected by RT-PCR to be 
expressed maternally and zygotically during the 6 day development period. (B-E) 
The spatial expression pattern of gp78 was analyzed by in situ hybridization using 
a dig-labeled gp78 antisense probe. 4 dpf (B with eyes, C with eyes removed) and 
5 dpf (D with eyes, E with eyes removed) embryos were analyzed. (F) The tissue 
expression pattern of gp78 in adult zebrafish was analyzed by Western blot using 
the anti-gp78 monoclonal antibody 1F1. (G) A similar tissue expression pattern of 




4)  Knockdown of gp78 expression did not result in developmental defects 
To test whether or not gp78 functions in early development, we performed a 
knockdown analysis of gp78 in zebrafish embryos. A 5’-UTR translational blocker 
was designed to target the 5’-UTR region of the transcript. 5–10 ng morpholino was 
injected into zebrafish embryos at 1- to 2-cell stage and the effect on gp78 was 
analyzed at different stages by Western blotting (Fig. 8 A-B). As shown in Fig. 8A, 
injection of the 5’-UTR morpholino dramatically knocked down gp78 at 24 and 48 
hpf (Fig. 8 A). To determine the efficacy of this morpholino, the expression levels 
were analyzed in wild-type and morphant embryos (embryos injected with 5’-UTR 
morpholino at the 1- or 2-cell stage) at 96 hpf and 120 hpf (Fig. 8 B). Compared with 
wild-type embryos, the gp78 expression levels were significantly reduced in the 
morphant embryos at 96 hpf and 120 hpf (Fig. 8 B), indicating that the morpholino 
effectively knocks down the expression of gp78 in the cells of zebrafish embryos. To 
determine whether or not the knockdown of gp78 caused developmental defects, the 
morphant embryos were examined morphologically every day for 7 days after the 
injection. The morphant embryos were morphologically normal at 48 and 72 hpf (Fig. 
8 C-D) and at the early developmental stages up to 7 dpf (data not shown). Moreover, 
we did not observe any developmental defects in the liver in wild-type fish embryos 
at 72 hpf (Fig. 8 D). To further investigate whether the knockdown of gp78 affects 
liver development, a transgenic fish line (hfe2:gfp also named as RGM-GFP) 
expressing green fluorescent protein (GFP) specifically in the liver was used for the 
knockdown experiments to assay the effect of the knockdown on liver development. 




F) and at the early developmental stages up to 7 dpf (data not shown). The morphant 
embryos could be raised without any defects. These data suggest that gp78 might not 





































































Fig. 8. Normal development of gp78-knockdown embryos.  
(A) Western blotting showed a dramatic reduction in the protein levels of gp78 
in morpholino (MO)-knockdown embryos at 24 hpf and 48 hpf. (B) The gp78 
protein levels in 96 hpf and 120 hpf larvae were also analyzed and were 
significantly reduced by 5'-UTR-MO. (C, D) The morphant embryos were 
morphologically normal at 48 and 72 hpf and normal liver morphology was seen 
in the morphant embryos at 72 hpf. (E, F) A transgenic fish line (hfe2:gfp, also 
called RGM-GFP) expressing GFP specifically in the liver was injected with the 
5'-UTR-MO and the morphant embryos showed normal liver morphology at 96 




5)  Overexpression of gp78-wt or gp78-R2M did not result in developmental defects 
To further test whether gp78 plays a role in early embryonic development, we 
generated transgenic fish lines that ubiquitously expressed a myc-tagged wild-type 
gp78 (gp78-wt
myc
) or dominant-negative gp78 (gp78-R2M
myc
) minigene driven by the 
ef1α promoter. As shown, 2 histidine residues, H354 and H357 in the RING finger 
domain, critical for the E3 ubiquitin ligase activity of gp78, were mutated to 
asparagine residues (N354 and N357) in the Tol2-ef1α:gp78-R2M
myc
 construct (Fig. 9 
A). Transient expression of the gp78-wt
myc
 minigene was detected in 24 hpf wild-type 
embryos injected with the Tol2-ef1α:gp78-wt
 myc
 construct (Fig. 9 B). Expression of 
the gp78-wt
myc
 minigene was detected in the 24 hpf embryos of 2 ef1α:gp78-wt
 myc
 
transgenic lines by RT-PCR (Fig. 9 C). Overexpression of total gp78 (the expression 
of endogenous gp78 and that of the ectopic gp78-wt
myc
 minigene) in these 2 lines was 
confirmed by Western blot using the monoclonal antibody 1F1 as previously 
described (Yang et al 2010) (Fig. 9 D). Overexpression of total gp78 (the expression 
of endogenous gp78 and that of the ectopic gp78-R2M
myc
 minigene) was also 
observed in 2 ef1α:gp78-R2M
myc
 transgenic lines (lines #11 and #12) (Fig. 9 E). 
Together we successfully showed genetic manipulation of gp78 expression in our 
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Fig. 9. Overexpression of gp78-wt and gp78-R2M in transgenic lines.  





constructs. 2 critical histidine residues H354 and H357 in the RING finger 
domain were mutated to asparagine residues (N354 and N357) to generate the 
R2M mutant. (B) The Tol2-ef1α:gp78-wt
 myc
 construct was injected into embryos 
at the 1- or 2-cell stage and the expression of gp78-myc was detected by whole 
mount anti-myc tag antibody staining. (C) Expression of the gp78-wt-myc 
minigene was detected in 24-hpf embryos of 2 ef1α:gp78-wt
 myc
 transgenic lines 
by RT-PCR. (D) Overexpression of gp78 in these 2 lines was confirmed in the 
embryos at 24 hpf by Western blot using the monoclonal antibody 1F1. (E) 
Overexpression of gp78-R2M in the 2 lines was also confirmed in the embryos 





5.  Discussion 
    In this study, we demonstrated that gp78 does not play a major role in 
embryonic development. Neither the knockdown of gp78 at early stages of 
development nor the overexpression of wild-type or dominant-negative gp78 resulted 
in developmental defects. To our knowledge, this is the first demonstration of a lack 
of a role for gp78 in embryonic development in animals. Despite the fact that gp78 is 
maternally and continuously expressed during early embryonic development and 
Hrd1 (SYVN1) homozygous knockout mice are embryonic lethal due to severe 
anemia probably caused by enhanced apoptosis of embryonic erythrocytes in the liver 
(Yagishita et al 2005), why the genetic manipulation of gp78 does not disrupt the 
normal development of zebrafish remains unclear.  
Interestingly, XBP1 homozygous knockout mice are also embryonic lethal due 
to defects in liver development and plasma cell differentiation (Reimold et al 2000). It 
is possible that the XBP1 transcription factor plays a critical role in liver development 
and plasma cell differentiation while one of its UPR target genes, Hrd1, controls 
apoptosis of embryonic erythrocytes in the liver, and gp78 has no role in these 
processes. Given that Hrd1 and gp78 are homologs, it is still possible that Hrd1 might 
regulate some exclusive substrates that are critical for controlling apoptosis in 
embryonic erythrocytes in the liver, which might explain the lack of a phenotype in 
gp78-knockdown embryos. Substrates both common and distinct to gp78 and Hrd1 
have been identified (Ballar et al 2010). Alternatively, abnormal phenotypes in gp78 




e.g. induction of ER stress by alcohol treatment. In terms of embryonic ER stress, we 
showed high expression of spliced xbp-1 in eggs dissected from female adult 
zebrafish, indicating strong ER stress in the unfertilized egg (Chen, Z, Fang, S, and 
Du, S, unpublished data). It is possible that the maternal expression of gp78 may 
provide an advantage in facilitating the degradation of misfolded proteins in 
unfertilized eggs. However, although we do not observe developmental defects, we 






















Table 3. List of primers, their sequences and PCR cycles.  
The primer names refer to the gene which they were designed against and restriction 
site if added.  














GP78-Mu-P1 CCTGCGGAAACCTTTTCAACAATTCCTG  
GP78-Mu-P2 CAGGAATTGTTGAAAAGGTTTCCGCAGG  
IVS-E1E2-P1 GATCCTGAGAACTTCAGGCTCCT  
Gp78-I-P3 TGTGCATGACCTCCACTGAGAAACT  
HindIII-gp78-P1 CCCGAAGCTTATGCCTCTGCTGTTTCTGGA  











AMFR-P3 GGAGGTGGTGCTGTGGTGTC  30 
AMFR-P4 ATGACCTCCACTGAGAAACT 30 
Bip-p1 ATGCGGTTGCTTTGCCTGTTTTTGCTG   27 
Bip-p2 CTACAGCTCGTCCTTCTCTTCGGCCTCTTCA 27 
Chop-P1 AGTTGGAGGCGTGGTATGA 30 
Chop-P2 AGATCTCCGGATGAGGTGTT 30 
Derlin1-P1 GGTTTGCTGGCTCCATTGCT   30 
Derlin1-P2 GGCATGGGTCTCCTGCTTGG   30 
VCP-P1 TCGTCAGGCTGCTCCTTGTG   30 
VCP-P2 TCCTTGGTTACTGGATGGGAAT   30 
Xbp1-P1 GCAGGAGATCAGACTCAGAGTCTG 30 
Xbp1-P2 CGAGACAAGACGAGTGATCTGCT 30 
EF1α-P1 GCATACATCAAGAAGATCGGC 18 
EF1α-P2 GCAGCCTTCTGTGCAGACTTTG 18 




Acc1-P2 GCTGCTGCCATCATACGAGA 30 
Fasn-P1 GAGAAAGCTTGCCAAACAGG 23 




Fasn-P2 GAGGGTCTTGCAGGAGACAG 23 
Fads2-P1 GCAGACAGACCGAATCACCG 22 
Fads2-P2 CGCAAATGCTCCGTACAAGG   22 
Hmgcs1-P1 GGTCGTTACGCTCTGGTTGT   30 
Hmgcs1-P2 GATACGGGGCATCTTCTTGA   30 
Hmgcra-P1 CTGAGGCTCTGGTGGACGTG 25 
Hmgcra-P2 ATCGGTTGCGGTCTGAAAAT   25 
Hmgcrb-p P1 GCCTGTTAGCCGTCAGTGGA   25 
Hmgcrb- P2 TCGTGTCGTCGCTGCCTTGT   25 
Srebp1-P1 GTAGCATCGCCCTGCATTACAACA   27 
Srebp1-P2 CCAGCGGGTTAAAGGACAGAAACA   27 
Srebp2-P1 AACGCTACCGCTCCTCCATCAA   27 
Srebp2-P2 CTCGTGCCTCCCTCCAACCA   27 
Cyp2e1-P1 GGTGGACCAGGCTGACGACT   27 









Chapter 3: Functional Characterization of the Role of gp78 
in Hepatic ER Stress and Lipid Metabolism in Zebrafish 
1.  Abstract 
The enhancement of ERAD activity by the UPR represents one of the 
mechanisms used to restore ER homeostasis. However, the significance of gp78 in the 
regulation of hepatic ER stress in vivo remains elusive. Here we report that zebrafish 
gp78 plays a key role in the regulation of hepatic ER stress under tunicamycin-
induced stress conditions but not under physiologic conditions. Tunicamycin 
treatment induces ER stress and upregulates the expression of several key 
components of the gp78-mediated ERAD complex in the liver. Moreover, hepatic 
specific overexpression of the dominant-negative form of gp78 (gp78-R2M) renders 
the liver more sensitive to ER stress induced by tunicamycin, suggesting a role for 
gp78-mediated ERAD in the regulation of hepatic protein homeostasis. Furthermore, 
the overexpression of gp78-R2M enhanced the expression of Srebp target genes in 
response to ER stress, while this was not observed in fish overexpressing wild-type 
gp78 (gp78-wt). Together, these data indicate that gp78 plays a critical role in the 
regulation of hepatic ER stress and lipid metabolism.   
2.  Introduction 
The transcriptional upregulation of ERAD components represents one of the 
mechanisms used to maintain ER protein homeostasis. Under several conditions, the 
inefficient clearance of misfolded proteins leads to their accumulation in the ER 




signaling transduction pathway that restores ER protein homeostasis (Schröder, et al 
2005). The UPR has been shown to exist in organisms from yeast to humans. Under 
stress conditions, the dissociation of BiP from 3 ER transmembrane proteins called 
IRE1α, PRKR-like endoplasmic reticulum kinase (PERK), and ATF6, causes a 
change in their conformation and activates the UPR pathway (Schröder M & 
Kaufman RJ 2005).  
 These 3 transmembrane proteins serve as sensors that transmit information 
about the protein folding status in the ER lumen to the cytosol, where active forms of 
transcription factors are generated via distinct mechanisms. The active forms of 
transcription factors then go into the nucleus to activate the expression of their target 
genes, including chaperones and components of the ERAD pathway, leading to the 
maintenance of ER protein homeostasis (Ye 2005, Lee 2005). 
The activation of the UPR by ER stress has been shown to be one of the causes 
of hepatic steatosis and fatty liver disease (Basseri & Austin 2008). All 3 branches of 
the UPR play roles in hepatic steatosis (Rutkowski et al 2008). Interestingly, the 
overexpression of BiP, a heat-shock protein 70 homolog that represents a type of 
target gene of the UPR pathway, has been shown to protect against insulin and ER 
stress-induced hepatic steatosis by reducing the activation of SREBP-1c in mice 
(Kammoun et al 2009). gp78, an E3 ubiquitin ligase that represents the other type of 
target gene of the UPR pathway, may play a role in the protection against hepatic 
steatosis and fatty liver disease. 
In addition, recent studies have demonstrated that gp78 might play a role in ER 




gp78-mediated ERAD by suppressing autoubiquitination of gp78 and leading to its 
stabilization (Shen et al 2007). In addition, gp78 counteracts ER stress induced by 
mutant superoxide dismutase 1 (SOD1) and ataxin-3 by repressing their aggregation 
and enhancing their degradation (Ying et al 2009). In contrast, compromising the 
function of gp78 in ERAD with mutant huntingtin via interaction with its CUE 
domain results in the inhibition of the interaction between gp78 and polyubiquitinated 
proteins and p97/VCP, thus triggering ER stress in cultured cells (Yang et al 2010). 
Similarly, cells with reduced levels of gp78 show increased sensitivity to cell death 
induced by ER stress (Tsai et al 2007). Besides, it has been reported that autocrine 
motility factor (AMF), the ligand of gp78, protects against tunicamycin-induced ER 
stress and this protection is gp78-dependent in HEK293 cells (Fu et al 2011).  
Moreover, it has become clear that gp78 is involved in targeting several hepatic 
proteins for degradation through the ERAD pathway according to studies using 
cultured cells. These substrates include HMG CoA reductase, a rate-limiting enzyme 
in cholesterol biosynthesis in the liver, and Apo-B100, a protein mainly synthesized 
in the liver according to in vitro studies (Song et al 2005, Liang et al 2003). gp78 also 
increases the solubility of and facilitates the degradation of the liver disease 
asscociated Z variant (1)-antitrypsin protein, ATZ, in cultured cells (Shen et al 
2006). gp78 has been reported to be involved in the proteasomal degradation of 
CYP3A, a dominant liver cytochrome P450 enzyme responsible for drug metabolism, 
and liver CYP2E1, which is responsible for the biotransformation of clinically 
relevant drugs, low molecular weight xenobiotics, carcinogens and endogenous 




function of gp78 in vivo is further demonstrated by its high level of expression in the 
liver as compared with other organs (Ballar, P and Fang, S, unpublished data). So far, 
no literature on gp78-knockout mice has been published. Thus, the significance of 
gp78 in the regulation of hepatic ER stress under physiologic or stress conditions in 
vivo remains unknown.  
The zebrafish has been shown to be an ideal system for studying hepatic ER 
stress, lipid metabolism, hepatic steatosis, and alcoholic or non-alcoholic fatty liver 
disease for the following reasons: facility of exposing to chemicals, the sensitivity of 
its liver to environmental or genetic perturbation, the lack of effect of external 
nutrients on its liver functions during early developmental stages, easy genetic 
manipulation, such as the generation of transgenic models or transient morpholino 
knockdown of gene expression, relatively low cost, a large number of offspring, 
external development of embryos, functional conservation of metabolic pathways 
with mammals, transparency, and quick generation time (Lieschke & Currie 2007, 
Nasevicius & Ekker 2000, Passeri et al 2009, Hölttä-Vuori et al 2010). Using 
transgenic fish that overexpress the dominant-negative form of gp78 in the liver and 
using morpholino knockdown of gp78, we report here that the gp78-mediated ERAD 
pathway plays a key role in the regulation of hepatic ER stress and lipid metabolism. 
These findings not only provide evidence of links between the UPR and lipid 
metabolism but also hold therapeutic potential for liver steatosis and alcoholic or non-
alcoholic fatty liver diseases.  
3.  Materials and Methods 




Adult zebrafish were raised and maintained as described in Chapter 2 until 
treatment with either tunicamycin. 2 to 3 month-old fish were exposed to 1 ug/mL 
tunicamycin dissolved in dimethyl sulfoxide (DMSO), in 50 mL fresh fish water for 
the indicated time described in the result section at 28 C during the day.  
2) Whole-mount in situ hybridization 
Probes were generated by PCR amplification from a cDNA library generated 
from 5 dpf larvae. All primers are listed in the Table 3. Each PCR product was 
cloned into pGEMT-easy (Promega) and was sequenced. Followed by linearization 
with restriction enzymes, the constructs were transcribed with either SP6 or T7 RNA 
polymerase using a digoxigenin RNA labeling mix (Roche). In detail, the gp78 
antisense probe was synthesized using the pGEM-gp78 plasmid as a template. pGEM-
gp78 was linearized with NcoI and transcribed with SP6 RNA polymerase. The bip 
antisense probe was synthesized using the pGEM-bip plasmid as a template. The 
pGEM-bip plasmid was linearized with EcoRV and transcribed with SP6 RNA 
polymerase. The chop antisense probe was synthesized using the pGEM-chop 
plasmid as a template. The pGEM-chop plasmid was linearized with Sac II and 
transcribed with SP6 RNA polymerase. The p97 antisense probe was synthesized 
using the pGEM-p97 plasmid as a template. The pGEM-p97 was linearized with Sal I 
and transcribed with T7 RNA polymerase. The derlin1 antisense probe was 
synthesized using the pGEM-derlin1 plasmid as a template. The pGEM-derlin1 
plasmid was linearized with Sac II and transcribed with SP6 RNA polymerase. The 
antisense probe for fabp10a was generated as described previously (Bian et al 2011). 








Derlin1-P1 GGTTTGCTGGCTCCATTGCT   
Derlin1-P2 GGCATGGGTCTCCTGCTTGG   
P97/VCP-P1 TCGTCAGGCTGCTCCTTGTG   
VCP/VCP-P2 TCCTTGGTTACTGGATGGGAAT   
3) Semi-quantitative RT-PCR 
Total RNA was isolated from dissected livers with the Trizol reagent (Invitrogen, 
CA, USA). 1 ug of total RNA was used for the synthesis of cDNA using the first-
strand cDNA synthesis kit (Fermentas). The synthesized cDNA was diluted 10-fold 
and 1 ul of diluted cDNA was used for PCR reactions. All 12.5 ul of PCR reaction 
solutions were used in DNA agarose gel electrophoresis. Primers and PCR cycles are 
listed in Table 3. The band intensities were quantified with free NIH Image J 
software.  




 constructs and transgenic 
fish 
To generate DNA constructs expressing a myc-tagged gp78 under a liver 





 constructs were replaced with a liver specific promoter, RGM promoter 





. In brief, a 6-kbp RGM promoter was amplified with primers 
RGM-p-XhoI-p1 and RGM-p-XhoI-p2 and then subcloned to pGEMT-easy vector to 
generate pGEMT-RGMp construct. XhoI-digested RGM-promoter was released from 
pGEMT-RGMp and subcloned to XhoI digested Tol2-eflα:gp78-wt
myc









site-directed mutagenesis using primers gp78-Mu-P1 and gp78-Mu-P2. The 
generation of transgenic fish and detection of exogenous transcript were performed as 
described in Chapter 2.  
RGM-p-XhoI-p1 CTCGAGTCCTGGAGGCCAAATATAGACAAGCA 
RGM-p-XhoI-p2 CTCGAGCCATACAGACACAGGCAGGACGGCCT 
5) Immunostaining of whole-mount fish embryos 
Immunostaining was carried out using whole-mount zebrafish embryos as 
described in Chapter 2.  
6) Western blot analysis 
Adult fish livers were dissected from female wild type (WT) or transgenic fish at 
2 to 3 months of age and snap-frozen in liquid nitrogen and stored at -80 C. 
Dissected livers were homogenized in buffer consisting of 20 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) HEPES-KOH (pH 7.4), 100 mM KCl, 
2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 10 μg/mL 
leupeptin, 1 μg /mL pepstatin A and 1 % Triton X-100. 20-40 μg of liver samples 
were used each lane. Proteins were electrophoretically transferred onto a 
polyvinylidene fluoride (PVDF) membrane (Immobilion-P; Millipore). 
Immunodetections were carried out by incubating with primary antibodies 
recognizing gp78 (1F1; Hui Yang et al 2010), Bip (1:3000; sigma), and γ-tubulin 
(1:2000; Sigma) followed by incubation with peroxidase-conjugated secondary 
antibodies. The band intensities were quantified with NIH Image J software.  
4.  Results 




Molecular chaperones and components of ERAD are 2 major types of UPR 
target genes. However, whether or not components of gp78-mediated ERAD are 
upregulated by the UPR remains undetermined. To establish a model for studying ER 
stress, we exposed fish embryos to 1 μg/mL of tunicamycin, a protein N-
glycosylation inhibitor and a well-known ER stress inducing agent, starting at 3–3.5 
dpf as previously described (Passeri et al 2009). After 48 h treatment, the fish larvae 
were sampled and subjected to whole mount in situ hybridization for the ER stress 
markers bip and chop. Interestingly, the results showed elevated expression of bip and 
chop mainly in the liver of fish larvae treated with tunicamycin (Fig. 10 A-B). No 
change in expression was observed using a liver specific probe Fabp10a (Fig. 10 F). 
Next, we examined whether tunicamycin could induce ER stress in the livers of adult 
zebrafish. RT-PCR results showed that adult fish exposed to 2.5 μg/mL of 
tunicamycin for the indicated periods of time displayed elevated levels of bip, chop, 
and xbp1-s at the transcript level (Fig. 11 A). Consistently, a marked increase of bip 
was observed at the protein level (Fig. 11 B). All together, these data suggest that 
tunicamycin induces ER stress in the liver of larval and adult zebrafish. 
2)  Tunicamycin treatment upregulates components of the gp78 complex in the liver 
To determine whether or not the activation of UPR by ER stress upregulates 
components of the gp78 complex in our model system, fish embryos similarly treated 
tunicamycin were subjected to whole mount in situ hybridization for the genes 
encoding the known components of the gp78 complex, gp78, p97/VCP and derlin1. 
Elevated mRNA expression of them these transcripts was observed in response to 




fish treated with 2.5 μg/mL tunicamycin for the indicated periods of time, elevated 
levels of these transcripts were also seen (Fig. 11 A). Consistently, an increase of 
gp78 was observed at the protein level (Fig. 11 B). All together, these data suggest 
that activation of the UPR by tunicamycin results in the upregulation of gp78 and its 

















































Fig. 10. Induction of hepatic ER stress and upregulation of the components 
of the gp78 complex by tunicamycin treatment in zebrafish larvae. 
(A, B) In situ hybridization results showing the upregulation of the ER stress 
marker bip in the livers of 5.5 dpf larvae treated with 1 μg/mL tunicamycin for 
48 h. (C-E) In situ hybridization results showing the upregulation of the 
components of the gp78 complex, namely gp78, derlin1, and p97/VCP, in the 
livers of 5.5 dpf larvae treated with 1μg/mL tunicamycin for 48 h. (F) In situ 
hybridization results showing the same expression level of the fabp10a 
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Fig. 11. Induction of hepatic ER stress and increased expression of the 
components of the gp78 complex upon tunicamycin treatment in adult 
zebrafish.  
(A) RT-PCR result showing the upregulation of the ER stress markers bip, chop, 
and the spliced form of xbp1 (s-xbp1) in the livers of adult fish treated with 2.5 
μg/mL tunicamycin for the indicated periods of time. The results also showed 
the upregulation of gp78, derlin1, and p97/VCP in the livers of adult fish treated 
with 2.5 μg/mL tunicamycin for the indicated periods of time. (B) Consistently, 
an increase of Bip and gp78 was observed at the protein level in the livers of 





3)  Overexpression of the dominant-negative form of gp78 (gp78-R2M) in the liver 
renders adult zebrafish more sensitive to tunicamycin-induced hepatic ER stress 
To test the liver specific function of gp78 in hepatic ER stress and to study the 
long-term effects in adult fish, transgenic fish lines expressing dominant-negative 
gp78 (gp78-R2M) specifically in the liver were generated (Fig. 12). It has been 
shown that a mutation in the RING finger domain of gp78, giving rise to the mutant 
gp78-R2M, exhibits dominant-negative effects on the degradation of several 
substrates, including CD3δ, CFTRF508, and HMG CoA reductase (Fang et al 2001, 
Zhong et al 2004, Pallar et al 2010). We asked whether the overexpression of this 
dominant-negative gp78 (gp78-R2M) specifically in the liver renders the liver more 
sensitive to tunicamycin-induced ER stress. We detected the transient expression of 
gp78-R2M
myc
 in by whole mount immunostaining in wild-type fish embryos injected 
with the Tol2-RGM:gp78-R2M
myc
 construct and the ectopic expression of the 
transgene by RT-PCR (Fig. 12 B-C).  The overexpression of the transgene was 
confirmed by Western blot using dissected livers from adult fish and whole mount in 
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Fig. 12. Liver specific overexpression of gp78-R2M in transgenic fish.  
(A) Schematic of the Tol2-RGM:gp78-R2M
myc 
construct. 2 critical histidine 
residues, H354 and H357 in the RING finger domain, were mutated to 
asparagine residues (N354 and N357) to generate the R2M mutant. (B) The 
Tol2-RGM:gp78-R2M
myc
 construct was injected into embryos at the 1- or 2-cell 
stage and the transient expression of gp78-R2M-myc was detected by whole 
mount anti-myc tag antibody staining. (C) Expression of the gp78-R2M-myc 
minigene was detected in the livers of adult fish of 2 RGM:gp78-R2M
myc
 
transgenic lines by RT-PCR. (D) Overexpression of gp78-R2M in these 2 lines 
was confirmed by Western blot using the monoclonal antibody 1F1 and 
dissected livers. (E) Liver-specific overexpression of gp78-R2M in the 2 lines 
was also confirmed in 5.5 dpf larvae by whole mount in situ hybridization using 




To examine the long-term effects of the overexpression of gp78-R2M on hepatic 
ER stress under physiologic conditions, livers dissected from 2-month-old adult wild-
type and transgenic fish were subjected to RT-PCR for 2 ER stress markers bip and 
chop. No significant difference was observed at the transcript level of these 2 ER 
stress markers under physiologic conditions (Fig. 13 A-D). Next, to examine the 
hepatic ER stress levels under the stressed condition, 2-month-old adult zebrafish 
were treated with 2.5 μg/mL tunicamycin for 6 h. As expected, the overexpression of 
gp78-R2M rendered adult zebrafish more sensitive to tunicamycin-induced hepatic 
ER stress as shown by semi-quantitative RT-PCR (Fig. 13 A-D). The level of bip 
mRNA in the livers of tunicamycin treated R2M-transgenic fish was dramatically 
increased compared with that in tunicamycin treated wild-type fish. The difference in 
chop mRNA levels was not striking (Fig. 13 A-D). Consistently, we observed the 
enhanced protein level of Bip in R2M transfected HeLa cells treated with 2μg /mL of 
tunicamycin (Fig. 13 O).  
4)  Overexpression of gp78-R2M in the liver enhances the expression of Srebp 
target genes in response to ER stress  
It has been demonstrated that ER stress activates the SREBP transcription 
factors, key regulators of fatty acid and cholesterol synthesis, in insulin- and alcohol-
induced hepatic steatosis (Kammoun et al 2009). Since we observed enhanced 
sensitivity to hepatic ER stress in the adult R2M-transgenic fish in response to 
tunicamycin, we next checked the mRNA levels of Srebp target genes involved in the 
synthesis of fatty acids and cholesterol. RT-PCR analysis revealed that the mRNA 




synthase (fasn)) and Srebp-2 target genes, (3-hydroxy-3-methylglutaryl coenzyme A 
reductase a (HMGCRa), 3-hydroxy-3-methylglutaryl coenzyme A synthase 1 
(HMGCS1)) were dramatically increased in the livers of R2M-transgenic fish 
compared with wild-type fish after tunicamycin challenge for 6 h (Fig. 13 A, E-J). 
Consistent with this, we also observed the upregulation of Srebp1 and Srebp2 
transcripts in the livers of R2M-transgenic fish (Fig. 13 A, K-L). Importantly, we did 
not observe the enhanced expression of cyp2e1, a key enzyme in drug metabolism, in 
R2M-transgenic fish (Fig. 13 A, M), indicating the upregulation of Srebp target genes 




































































































































































































































Overexpression of dominant-negative form of gp78 sensitizes hepatic ER stress 
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Fig. 13. Overexpression of the dominant-negative form of gp78 sensitizes hepatic 
ER stress and enhances the expression of Srebp target genes in response to ER 
stress.  
(A-M) 2-month-old adult wild-type and transgenic fish were treated with or without 
2.5 μg/mL tunicamycin for 6 h. Livers were dissected and subjected to semi-
quantitative RT-PCR for the ER stress markers bip and chop, the Srebp-1c target 
genes acc1, fads, and fasn, the Srebp-2 target genes hmgcra, and hmgcs1, srebp1, 
srebp2, and cyp2e1. No significant differences were observed at the transcript levels 
for bip and chop under the treated and untreated conditions. However, the 
overexpression of gp78-R2M enhanced the expression of the ER stress markers bip 
and chop in response to tunicamycin treatment. This was accompanied by the 


























target genes, hmgcra, and hmgcs1 as well as increased srebp1 and srebp2 transcripts, 
but not increased cyp2e1 transcripts. (O) We consistently observed enhanced protein 





5) Overexpression of gp78-wt in the liver renders the liver less sensitive to 
tunicamycin-induced hepatic ER stress 
To further test the liver specific function of gp78 in regulation of hepatic ER 
stress and lipid metabolism, transgenic fish lines expressing gp78-wt specifically in 
the liver were generated (Fig. 14). Next we asked whether the specific overexpression 
of gp78-wt in the liver renders the liver less sensitive to tunicamycin-induced ER 
stress. Again, we detected the ectopic expression of the transgene by RT-PCR and 
confirmed its overexpression by Western blot using livers dissected from adult fish 





















































































Fig. 14. Liver specific overexpression of gp78-wt in transgenic fish.  
(A) Schematic of the Tol2-RGM:gp78-wt
myc
 construct. (B) Expression of the gp78-
wt-myc minigene was detected in the livers of adult fish of 2 RGM:gp78-wt
myc
 
transgenic lines by RT-PCR. (C) Overexpression of gp78-wt in these 2 lines was 
confirmed by Western blot using the monoclonal antibody 1F1 on dissected livers. 
(D) Liver specific overexpression of gp78-wt in the 2 lines was also confirmed in 





To examine the long-term effects of the overexpression of gp78-wt on hepatic 
ER stress, 2-month-old adult zebrafish were subjected to treatment with 2.5 μg/mL 
tunicamycin for 6 h. As expected, the overexpression of gp78-wt rendered zebrafish 
less sensitive to tunicamycin-induced hepatic ER stress as shown by semi-quantitative 
RT-PCR (Fig. 15 C-D). The increased level of bip mRNA in the livers of 
tunicamycin treated fish was attenuated in RGM:gp78-wt
myc
 transgenic fish (Fig. 15 
D), although the chop mRNA levels were slightly increased (Fig. 15 C). Consistently, 
no change in expression of Bip protein was observed between non-transfected and 
R2M-transfected HeLa cells treated with 2μg /mL of tunicamycin (Fig. 15 O). 
6)  Overexpression of gp78-wt in the liver did not enhance the expression of Srebp 
target genes in response to ER stress  
To further test whether the overexpression of gp78-wt affects the expression of 
Srebp target genes in response to tunicamycin-induced ER stress, we determined the 
mRNA levels of Srebp target genes by RT-PCR analysis. The results revealed that the 
mRNA levels of both the Srebp target genes, acc1, fads and fasn, and Srebp-2 target 
genes, hmgcra, hmgcs1, were not affected (Fig. 15 A, E-J). Consistent with this, 
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Overexpression of wt-gp78 renders less sensitive to hepatic ER stress and 
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Fig. 15. Overexpression of gp78-wt renders less sensitive to hepatic ER stress and 
does not enhance the expression of Srebp target genes in response to ER stress.  
(A-M) 2-month-old adult wild-type and gp78-wt transgenic fish were treated with or 
without 2.5 μg/mL tunicamycin for 6 h. Livers were dissected and subjected to semi-
quantitative RT-PCR for the ER stress markers bip and chop, the Srebp-1c target 
genes acc1, fads, and fasn, the Srebp-2 target genes, hmgcra, hmgcs1, srebp1, srebp2, 
and cyp2e1. No significant differences were observed at the transcript levels of bip 
and chop under the treated and untreated conditions. The overexpression of gp78-R2M 
neither enhanced the expression of the ER stress markers bip and chop in response to 
tunicamycin treatment, nor enhanced the expression of the Srebp1 target genes acc1, 



























increased srebp1 and srebp2 transcript levels. (O) We consistently observed a lack of 
enhancement of the protein levels of Bip in gp78-wt transfected HeLa cells treated 





In this study we analyzed the function of gp78 in hepatic ER stress in zhebrafish. 
We have demonstrated that gp78 plays a key role in the regulation of hepatic ER 
stress and lipid metabolism. Genetic manipulation of gp78 expression through 
morpholino knockdown or the overexpression of dominant negative gp78 does not 
affect hepatic ER stress under physiologic conditions but renders the hepatocytes 
more sensitive to ER stress in both larval and adult zebrafish. Moreover, our results 
indicate a potential role for gp78 in the regulation of Srebp cleavage induced by ER 
stress.  
1)  gp78 and UPR  
It has been demonstrated that HRD1, a gp78 homolog, is upregulated by ER 
stress and protects against ER stress-induced apoptosis by accelerating the 
degradation of misfolded proteins (Kaneko, et al 2007, Allen et al 2004). Recently, it 
has been shown that HRD1 promoter carries a functional unfolded protein response 
element (UPRE) to which XBP1 binds directly (Yamamoto et al 2008). However, 
whether gp78 carries a UPRE, and which branches of the UPR are responsible for 
gp78 to protect cells against ER stress, remains to be determined. Nevertheless, we 
demonstrated the upregulation of gp78, p97, and derlin1 upon tunicamycin treatment 
in our model system, although we do not rule out the possibility that other E3 ligases 
are upregulated and that the upregulation of p97 and derlin1 coordinately enhances 
the ERAD activity of other E3 ligases. It is also possible that different E3 ligases 
function in different tissues upon the activation of the UPR pathways. However, since 




the various E3 ligases remain unknown. Nevertheless, we demonstrated the 
significance of g78 in the UPR pathway and in hepatic function in vivo in the present 
study.  
2) gp78 and ER stress  
We have demonstrated that the knockdown of gp78 or the overexpression of 
gp78-wt or gp78-R2M does not induce hepatic ER stress under physiologic 
conditions. This result is consistent with a previous study showing that the 
overexpression of wild-type or mutant Hrd1 or gp78 alone could not induce massive 
ER stress in cultured cells (Bernardi et al 2010,). Interestingly, Bip, Hsp70 and p97 
levels were not altered upon gp78 knockdown (Fisher et al 2011). In contrast, another 
study showed that the knockdown of gp78 caused mutant SOD1-induced ER stress 
(Ying et al 2009). In HEK293 cells in which ER stress was induced by the co-
transfection of mutant SOD-1, the knockdown of gp78 increased the level of Bip, 
whereas the overexpression of gp78 decreased the level of Bip (Ying et al 2009). It 
should be noted that the ERAD-mediated degradation of SOD-1 is primarily driven 
by gp78 and is only slighted affected by Hrd1 (Ying et al 2009). Given that gp78 is 
the primary ubiquitin ligase that targets SOD-1 for degradation, the knockdown of 
gp78 will result in the accumulation of mutant SOD-1 and the induction of ER stress. 
These results are consistent with our finding that gp78 functions under stress 
conditions but not under physiologic conditions.  
3) gp78 and hepatic lipid metabolism 
We have demonstrated that gp78 may play a role in protecting against hepatic 




become clear that gp78 is involved in targeting several hepatic proteins responsible 
for lipid metabolism for degradation through the ERAD pathway. For example, gp78 
regulates the degradation of HMG CoA reductase, a rate-limiting enzyme in 
cholesterol biosynthesis in the liver, under high cholesterol conditions (Song et al 
2005, Jo et al 2010) and the secretion of ApoB-100, a protein mainly synthesized in 
the liver, in cultured cells (Liang et al 2003, Fisher et al 2011). Although some studies 
suggest that a high fat diet induces hepatic ER stress and thus causes hepatic steatosis, 
it is not clear whether such regulation works through the activation of the UPR 
induced by ER stress (Li et al 2012). The Srebp pathway is the key pathway 
responsible for lipogenesis in the liver, and here we showed that the overexpression 
of dominant-negative gp78 (gp78-R2M) renders hepatocytes more sensitive to 
tunicamycin-induced ER stress and thus enhances the upregulation of Srebp target 
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